<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">92406</article-id><article-id pub-id-type="doi">10.7554/eLife.92406</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.92406.3</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Divergent folding-mediated epistasis among unstable membrane protein variants</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chamness</surname><given-names>Laura M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3971-2799</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Kuntz</surname><given-names>Charles P</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>McKee</surname><given-names>Andrew G</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1238-987X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Penn</surname><given-names>Wesley D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Hemmerich</surname><given-names>Christopher M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Rusch</surname><given-names>Douglas B</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Woods</surname><given-names>Hope</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6615-545X</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Dyotima</surname></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Meiler</surname><given-names>Jens</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Schlebach</surname><given-names>Jonathan P</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0955-7633</contrib-id><email>jschleba@purdue.edu</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01kg8sb98</institution-id><institution>Department of Chemistry, Indiana University</institution></institution-wrap><addr-line><named-content content-type="city">Bloomington</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02dqehb95</institution-id><institution>The James Tarpo Jr. and Margaret Tarpo Department of Chemistry, Purdue University</institution></institution-wrap><addr-line><named-content content-type="city">West Lafayette</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01kg8sb98</institution-id><institution>Center for Genomics and Bioinformatics, Indiana University</institution></institution-wrap><addr-line><named-content content-type="city">Bloomington</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02vm5rt34</institution-id><institution>Department of Chemistry, Vanderbilt University</institution></institution-wrap><addr-line><named-content content-type="city">Nashville</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02vm5rt34</institution-id><institution>Chemical and Physical Biology Program, Vanderbilt University</institution></institution-wrap><addr-line><named-content content-type="city">Nashville</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03s7gtk40</institution-id><institution>Institute for Drug Discovery, Leipzig University</institution></institution-wrap><addr-line><named-content content-type="city">Leipzig</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Drew</surname><given-names>David</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05f0yaq80</institution-id><institution>Stockholm University</institution></institution-wrap><country>Sweden</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Swartz</surname><given-names>Kenton J</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01s5ya894</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>30</day><month>07</month><year>2024</year></pub-date><volume>12</volume><elocation-id>RP92406</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-09-14"><day>14</day><month>09</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-08-27"><day>27</day><month>08</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.08.25.554866"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-12-01"><day>01</day><month>12</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.92406.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-04-26"><day>26</day><month>04</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.92406.2"/></event></pub-history><permissions><copyright-statement>© 2023, Chamness et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Chamness et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-92406-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-92406-figures-v1.pdf"/><abstract><p>Many membrane proteins are prone to misfolding, which compromises their functional expression at the plasma membrane. This is particularly true for the mammalian gonadotropin-releasing hormone receptor GPCRs (GnRHR). We recently demonstrated that evolutionary GnRHR modifications appear to have coincided with adaptive changes in cotranslational folding efficiency. Though protein stability is known to shape evolution, it is unclear how cotranslational folding constraints modulate the synergistic, epistatic interactions between mutations. We therefore compared the pairwise interactions formed by mutations that disrupt the membrane topology (V276T) or tertiary structure (W107A) of GnRHR. Using deep mutational scanning, we evaluated how the plasma membrane expression of these variants is modified by hundreds of secondary mutations. An analysis of 251 mutants in three genetic backgrounds reveals that V276T and W107A form distinct epistatic interactions that depend on both the severity and the mechanism of destabilization. V276T forms predominantly negative epistatic interactions with destabilizing mutations in soluble loops. In contrast, W107A forms positive interactions with mutations in both loops and transmembrane domains that reflect the diminishing impacts of the destabilizing mutations in variants that are already unstable. These findings reveal how epistasis is remodeled by conformational defects in membrane proteins and in unstable proteins more generally.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>epistasis</kwd><kwd>membrane protein folding</kwd><kwd>protein misfolding</kwd><kwd>protein evolution</kwd><kwd>translocon</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>1342962</award-id><principal-award-recipient><name><surname>Chamness</surname><given-names>Laura M</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01GM129261</award-id><principal-award-recipient><name><surname>Schlebach</surname><given-names>Jonathan P</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Many of the synergistic interactions between mutations are modified in the context of unstable proteins in a manner that depends on how the variants promote misfolding in the cell.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Mutational effects on protein stability have important consequences for evolution. Destabilized proteins misfold more often, which can attenuate their ability to function in the cell (<xref ref-type="bibr" rid="bib5">Bloom et al., 2007</xref>; <xref ref-type="bibr" rid="bib20">Marinko et al., 2019</xref>). Though natural selection typically maximizes fitness by incorporating mutations that produce new or improved functions, this optimization process is often hindered by the destabilizing effects of most random mutations (<xref ref-type="bibr" rid="bib5">Bloom et al., 2007</xref>; <xref ref-type="bibr" rid="bib46">Tokuriki et al., 2007</xref>). The cumulative energetic effects of these mutations on protein stability are generally capable of creating non-additive, context-dependent epistatic interactions (<xref ref-type="bibr" rid="bib13">Gong et al., 2013</xref>; <xref ref-type="bibr" rid="bib30">Olson et al., 2014</xref>; <xref ref-type="bibr" rid="bib43">Starr and Thornton, 2016</xref>). Nevertheless, there are many different aspects of protein synthesis, folding, and assembly that are governed by distinct energetic constraints. While epistatic interactions arising from changes in protein stability have been previously characterized in soluble proteins (<xref ref-type="bibr" rid="bib13">Gong et al., 2013</xref>; <xref ref-type="bibr" rid="bib30">Olson et al., 2014</xref>; <xref ref-type="bibr" rid="bib10">Faber et al., 2019</xref>; <xref ref-type="bibr" rid="bib28">Nedrud et al., 2021</xref>), the impact of epistasis on membrane protein folding and stability has yet to be explored. Although many of the mechanistic underpinnings of pairwise epistasis in soluble proteins are likely to be generalizable to all proteins, membrane proteins undergo additional cotranslational folding reactions that are governed by mechanistically distinct kinetic and energetic constraints (<xref ref-type="bibr" rid="bib20">Marinko et al., 2019</xref>; <xref ref-type="bibr" rid="bib38">Schlebach and Sanders, 2015</xref>). Based on these considerations, we suspect that mutations in membrane proteins could potentially modify cotranslational processes in a manner that generates distinct epistatic interactions that bias their evolutionary pathways in unique ways.</p><p>Unlike water-soluble proteins, membrane proteins must be cotranslationally inserted into lipid bilayers (stage I folding) in order to fold into their native structure (stage II folding, see <xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="bibr" rid="bib35">Popot and Engelman, 1990</xref>). In eukaryotes, stage I folding is primarily facilitated by Sec61 and a spectrum of various other translocon complexes (<xref ref-type="bibr" rid="bib20">Marinko et al., 2019</xref>; <xref ref-type="bibr" rid="bib41">Smalinskaitė and Hegde, 2023</xref>). Ribosomes translating membrane proteins are targeted to this translocon complex at the endoplasmic reticulum (ER) membrane, where the nascent transmembrane domains (TMDs) partition into the lipid bilayer and establish their native topology relative to the membrane (stage I) (<xref ref-type="bibr" rid="bib33">Pfeffer et al., 2016</xref>; <xref ref-type="bibr" rid="bib35">Popot and Engelman, 1990</xref>; <xref ref-type="bibr" rid="bib48">Van den Berg et al., 2004</xref>). After translation is complete, membrane proteins fold and assemble (stage II) in a manner that is coupled to their passage through the secretory pathway to the plasma membrane and/or other destination organelles (<xref ref-type="bibr" rid="bib20">Marinko et al., 2019</xref>; <xref ref-type="bibr" rid="bib35">Popot and Engelman, 1990</xref>; <xref ref-type="bibr" rid="bib51">Wiseman et al., 2007</xref>). Though they are governed by distinct physicochemical constraints, failures in either stage I or II folding are capable of increasing the proportion of nascent membrane proteins that are retained in the ER and prematurely degraded (<xref ref-type="bibr" rid="bib20">Marinko et al., 2019</xref>; <xref ref-type="bibr" rid="bib51">Wiseman et al., 2007</xref>). We therefore expect that epistatic interactions can arise from the cumulative energetic effects of mutations on either of these processes. Given that three-dimensional protein structures are stabilized by similar energetic principles in water and lipid bilayers, mutations that modify the fidelity of stage II folding energetics should potentially generate long-range epistatic interactions that are comparable to those observed in soluble proteins (<xref ref-type="bibr" rid="bib20">Marinko et al., 2019</xref>). By comparison, the topological transitions that happen during the early stages of membrane protein synthesis may be coupled to neighboring loops and helices in a manner that can play a decisive role in the formation of the native topology (<xref ref-type="bibr" rid="bib16">Hessa et al., 2007</xref>; <xref ref-type="bibr" rid="bib29">Ojemalm et al., 2012</xref>; <xref ref-type="bibr" rid="bib50">White and von Heijne, 2008</xref>). Based on these mechanistic distinctions and their association with different components of the proteostasis network, we reason that the effects of mutations on these two processes could potentially create complex and/or high-order epistatic interactions (<xref ref-type="bibr" rid="bib27">Morrison et al., 2021</xref>; <xref ref-type="bibr" rid="bib37">Sailer and Harms, 2017</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Mutagenic perturbation of GnRHR folding.</title><p>(<bold>A</bold>) A cartoon depicts the manner in which nascent polytopic membrane proteins are synthesized and folded at the endoplasmic reticulum (ER) membrane. The nascent protein first passes from a ribosome (gray) to a translocon (yellow), which facilitates its cotranslational membrane integration (stage I folding). Once the protein establishes its topology with respect to the membrane, it can fold into its native tertiary structure (stage II folding). (<bold>B</bold>) A homology model of <italic>M. musculus</italic> GnRHR (mGnRHR, green) is aligned with a crystal structure of <italic>H. sapiens</italic> GnRHR (hGnRHR, PDB 7BR3, gray). (<bold>C</bold>) A cross section of the mGnRHR model depicts the structural context of the V276 side chain (red). This side chain is located in transmembrane domain 6 and is exposed to the lipid bilayer. (<bold>D</bold>) A side view of the mGnRHR model depicts the structural context of the W107 side chain within extracellular loop 1. A hydrogen bond network between the W107 side chain indole, the backbone carbonyl oxygen of G110, and the backbone amide hydrogen from C114 is shown with dashes for reference.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92406-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Membrane integration of mGnRHR TM domain 6 and V276T.</title><p>Chimeric Lep proteins containing either the wild type mGnRHR TM domain 6 or the V276T mutant, with the guest TM domain flanked by two glycosylation sites, were translated in vitro and analyzed by SDS-PAGE. Misintegration of the guest TM domain results in doubly glycosylated protein, while successful membrane integration results in singly glycosylated protein. Negative control translation reactions without RNA (first lane) and without rough microsomes (second lane) are included. The positions of the untargeted protein that is not associated with the membrane (no glycosylation), singly glycosylated form of the protein in which TMD6 is integrated into the membrane (G1), and doubly glycosylated form of the protein in which TMD6 is not integrated into the membrane (G2) are indicated for reference.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92406-fig1-figsupp1-v1.tif"/></fig></fig-group><p>To gain insights into the mechanistic basis of epistatic interactions in membrane proteins, we surveyed the effects of single and double mutants on the plasma membrane expression (PME) of the gonadotropin-releasing hormone receptor (GnRHR), a G-protein coupled receptor (GPCR) involved in reproductive steroidogenesis across many species (<xref ref-type="bibr" rid="bib18">Janovick et al., 2013</xref>; <xref ref-type="bibr" rid="bib17">Janovick et al., 2006</xref>). We have previously demonstrated that various evolutionary sequence modifications within mammalian GnRHRs have tuned its fitness by compromising the fidelity of stage I folding (<xref ref-type="bibr" rid="bib7">Chamness et al., 2021</xref>). Nevertheless, it remains unclear how the inefficient cotranslational folding of GnRHR reshapes its tolerance of secondary mutations. Here, we utilize deep mutational scanning (DMS) to carry out a focused analysis of 251 mutations in the background of two mouse GnRHR (mGnRHR) variants that selectively compromise either stage I or II folding. Our results show that mutations which generate stage I and II folding defects form distinct epistatic interactions throughout this receptor. An unsupervised learning analysis reveals how these interactions depend on both changes in stability and the topological context of the mutation. Together, these findings suggest that the distinct biosynthetic mechanisms of integral membrane proteins may differentially shape their fitness landscapes. The general implications of our findings for the role of protein folding and stability in protein evolution are discussed.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Mutational library design</title><p>To compare how perturbations of stage I and II folding shape epistatic interactions, we first identified and characterized two individual mutations that are likely to selectively disrupt either the cotranslational membrane integration (V276T) or the native tertiary structure (W107A) of mGnRHR. We previously showed that T277 in TMD6 of human GnRHR (hGnRHR) contributes to the inefficient translocon-mediated membrane integration of TMD6, which decreases the receptor’s PME (<xref ref-type="bibr" rid="bib7">Chamness et al., 2021</xref>). A recent crystallographic structure of hGnRHR confirms that the polar side chain of T277, which corresponds to V276 in the mouse receptor (89.3% sequence identity), is exposed to the lipid bilayer and does not appear to make interhelical contacts that stabilize the native structure (<xref ref-type="fig" rid="fig1">Figure 1B and C</xref>; <xref ref-type="bibr" rid="bib54">Yan et al., 2020</xref>). Thus, mutations at this position modify the hydrophobicity of TMD6 without perturbing the native tertiary contacts that stabilize the native fold. Indeed, replacing the native valine residue in TMD6 of the mouse receptor with the threonine residue found in hGnRHR reduces the efficiency of its translocon-mediated membrane integration in vitro (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Furthermore, this substitution decreases the PME of the mouse receptor by 65 ± 4% relative to that of wild-type mGnRHR (WT, <xref ref-type="fig" rid="fig2">Figure 2</xref>). Consistent with previous findings, these results confirm that the inefficient translocation of this helix promotes cotranslational GnRHR misfolding (<xref ref-type="bibr" rid="bib7">Chamness et al., 2021</xref>). In contrast, substitutions at W107 within extracellular loop 1 (ECL1) preserve the hydrophobicity of TMDs and their topological energetics while disrupting a conserved hydrogen bond network that is found in a wide array of GPCR structures (<xref ref-type="fig" rid="fig1">Figure 1D</xref>; <xref ref-type="bibr" rid="bib19">Jones et al., 2020</xref>). Mutating this conserved tryptophan to alanine (W107A) reduces the PME of mGnRHR by 88 ± 4% relative to WT (<xref ref-type="fig" rid="fig2">Figure 2</xref>), which suggests that disrupting this hydrogen bond network destabilizes mGnRHR in a manner that promotes its cellular misfolding. Comparing how these mutations modify the proteostatic effects of secondary mutations will therefore reveal how changes in the fidelity of stage I (V276T) and stage II (W107A) folding differentially impact mutational epistasis.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Plasma membrane expression of mGnRHR variants.</title><p>Surface immunostaining and flow cytometry were used to compare the plasma membrane expression of select mGnRHR variants expressed in HEK293T cells. A histogram from one representative biological replicate depicts the distribution of plasma membrane expression intensities among cells expressing WT (black), V276T (red), or W107A (blue) mGnRHR.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92406-fig2-v1.tif"/></fig><p>To survey the epistatic interactions formed by these mutations, we generated a series of genetic libraries consisting of 1615 missense variants in the background of V276T, W107A, and WT mGnRHR. To ensure adequate dynamic range in the downstream assay, we created these variants in the cDNA of mGnRHR, which exhibits intermediate, tunable expression (<xref ref-type="bibr" rid="bib7">Chamness et al., 2021</xref>). Briefly, we used a structural homology model of mGnRHR to select 85 residues distributed across the loops and helices of mGnRHR. We included all 19 amino acid substitutions at the 3 most solvent-accessible and the 3 most buried residues in each TMD (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). We also included mutations encoding all 19 amino acid substitutions at positions that are evenly distributed across each soluble domain. We then generated a mixed array of mutagenic oligonucleotides that collectively encode this series of substitutions (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>) and used nicking mutagenesis to introduce these mutations into the V276T, W107A, and WT mGnRHR cDNAs (<xref ref-type="bibr" rid="bib24">Medina-Cucurella et al., 2019</xref>), which produced three mixed plasmid pools. We generated each of these one-pot plasmid libraries in the context of vectors that contain a randomized ten-base region within the backbone. Unique ten-base plasmid identifiers that could be matched to a specific mGnRHR variant were used to score variants in the downstream assay using Illumina sequencing. Using whole plasmid PacBio sequencing of each library, we matched 1383 of the 1615 possible variants to one or more ten-base unique molecular identifier (UMI) in at least one of the three libraries, 320 of which were found in all three genetic backgrounds (see ‘Materials and methods’ for details).</p></sec><sec id="s2-2"><title>Plasma membrane expression of GnRHR mutant libraries</title><p>To identify secondary mutations that form epistatic interactions with V276T and W107A, we measured the relative PME of single and double mutants within each genetic library by DMS as previously described (<xref ref-type="bibr" rid="bib32">Penn et al., 2020</xref>). Briefly, we first used the genetic libraries described above to generate three recombinant, pooled HEK293T cell lines in which the individual cells each express one of the single or double mGnRHR mutants of interest. A comparison of the mGnRHR surface immunostaining profiles of these cellular populations that recombinantly express this collection of variants in context of the V276T, W107A, or an otherwise WT genetic background reveals striking context-dependent differences in their proteostatic effects. Recombinant cells expressing these variants in the WT background exhibit a bimodal distribution of mGnRHR surface immunostaining, where 59% of cells exhibit immunostaining that is comparable to WT and 41% of cells exhibit reduced expression relative to WT (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Although cells expressing this same collection of variants in the V276T background also exhibit bimodal surface immunostaining, 48% of the population exhibit diminished expression relative to the V276T variant (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). This observation suggests many of these variants synergistically decrease mGnRHR expression in combination with the V276T mutation. Unlike the WT and V276T libraries, cells expressing this same collection of variants in combination with the W107A mutation exhibit a continuous range of surface immunostaining intensities that are only slightly lower, on average, relative to cells expressing the W107A single mutant (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). The lack of dispersion likely reflects a compression of the distribution that arises as the folding efficiency of these variants approaches zero (see ‘Discussion’). Cells expressing this library of W107A double mutants do, however, still contain cellular subpopulations with surface immunostaining intensities that are well above or below that of the W107A single mutant, which suggests that this fluorescence signal is sensitive enough to detect subtle differences in the PME of these variants (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Indeed, the mean fluorescence intensity associated with the surface immunostaining of the WT, V276T, and W107A mutant libraries were respectively 33.5-fold, 13.5-fold, and 2.6-fold higher than the background, on average, across the two biological replicates. Overall, these results suggest that none of the secondary mutations can fully compensate for the proteostatic effects of the W107A mutation.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Plasma membrane expression of mGnRHR cellular libraries.</title><p>mGnRHR mutant libraries, as well as their respective controls (WT or V276T/W107A single mutants, black) were expressed in mammalian cells, and the amount of mGnRHR expressed at the plasma membrane was measured during fluorescence-activated cell sorting. Histograms show the distributions of plasma membrane expression for mGnRHR mutants in the (<bold>A</bold>) WT library (gray), (<bold>B</bold>) V276T library (red), and (<bold>C</bold>) W107A library (blue).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92406-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Structural context of mGnRHR library mutants.</title><p>Residues selected for mutation are displayed as spheres on the homology model of <italic>M. musculus</italic> GnRHR. Spheres are colored according to solvent accessible surface area of the residue, with red representing exposed residues and blue representing buried residues.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92406-fig3-figsupp1-v1.tif"/></fig></fig-group><p>To compare the PME of these variants in each genetic background, we fractionated each of the three mixed cell populations into quartiles based on the relative surface immunostaining of their expressed mGnRHR variants using fluorescence-activated cell sorting (FACS), then extracted the genomic DNA from each cellular fraction. We then used Illumina sequencing to track the relative abundance of the recombined UMIs and their associated variants within each fraction and used these measurements to estimate the corresponding PME of each variant. A series of filters relating to the quality of the reads, the sampling of each mutation, and the similarity of variant scores across replicates were used to remove poorly sampled variants with unreliable scores (see ‘Materials and methods’). Briefly, to restrict our analysis to variants that can be reliably scored, we removed variants that did not have at least 50 counts across the four bins in each replicate. Additionally, we compared the percentile rank of each variant across replicates and discarded variant scores for which the difference in percentile rank across the two replicates was greater than 25%. The relative PME of the remaining variants was averaged across two biological replicates. Overall, we measured the relative PME of 1004 missense variants in the WT background, 338 missense variants in the V276T background, and 1179 missense variants in the W107A background (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). Out of the 320 variants identified in all three plasmid libraries by PacBio sequencing, 251 mutations passed these quality filters in the Illumina sequencing of the cellular isolates (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). The intensity values for these variants were highly correlated across independent biological replicates, which demonstrates that these measurements exhibit precision despite variations in the signal-to-noise associated with their surface immunostaining (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). In the following, we will focus on the comparison of the effects of these 251 mutations in each background in order to determine how their proteostatic effects are modified by secondary mutations.</p><p>To facilitate the comparison of estimated immunostaining intensities for each variant across the three genetic backgrounds, we normalized the raw immunostaining intensity values for each variant relative to that of the measured intensity values for the corresponding reference sequence (V276T, W107A, or WT mGnRHR). Relative intensity values of 1.0 correspond to no effect, whereas values over 1.0 correspond to mutations that enhance surface expression in that genetic background, and vice versa. A histogram of the relative intensity values for the 251 variants measured in all three backgrounds generally recapitulates the trends in the cellular immunostaining histograms (<xref ref-type="fig" rid="fig3">Figures 3 and</xref> <xref ref-type="fig" rid="fig4">4A</xref>). Most of these mutations decrease the PME of mGnRHR in all three backgrounds, which reflects the limited mutational tolerance of membrane proteins (<xref ref-type="fig" rid="fig4">Figure 4A</xref>; <xref ref-type="bibr" rid="bib45">Telenti et al., 2016</xref>). Notably, only a modest fraction of mutations measurably enhance the surface expression of WT mGnRHR (51 mutations, 20%) and V276T mGnRHR (21 mutations, 8% <xref ref-type="fig" rid="fig4">Figure 4A</xref>). Mutations in the V276T background tend to decrease surface expression more than they do in the WT background, and this trend persists across most domains of the protein (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>). In contrast, a larger proportion of these mutations (100 mutants, 40%) enhance the surface expression of W107A (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), though these increases in immunostaining are relatively modest (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Furthermore, the mutations tend to be better tolerated with respect to surface expression in combination with W107A relative to their effects on expression in the WT background (<xref ref-type="fig" rid="fig4">Figure 4C</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Relative plasma membrane expression of mGnRHR mutants.</title><p>(<bold>A</bold>) A histogram shows the distribution of plasma membrane expression measurements relative to their respective controls (WT or V276T/W107A single mutants) for the WT (black), V276T (red), and W107A (blue) mutational libraries. A dashed line at the normalized plasma membrane expression value of 1.0, representing no mutational effect relative to the control, is displayed for reference. (<bold>B, C</bold>) The average relative intensities across each domain are compared between the V276T (<bold>B</bold>, red) and W107A (<bold>C</bold>, blue) double mutant libraries and the single mutant library (black). The size of each dot represents the number of variants measured. (<bold>D–F</bold>) Average relative intensities for the (<bold>D</bold>) WT library, (<bold>E</bold>) V276T library, and (<bold>F</bold>) W107A library were projected onto a homology model of mGnRHR. Scores represent the average value from two biological replicates. Residues 276 and 107 are displayed in green for reference. Individual variant scores can be found in <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92406-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Correlation of deep mutational scanning (DMS) variant intensity values across two biological replicates.</title><p>The intensity values for the surface immunostaining of the 251 mutants scored the (<bold>A</bold>) WT, (<bold>B</bold>) V276T, and (<bold>C</bold>) W107A backgrounds determined from two independent biological replicates are plotted against one another. A linear fit (dashes) is shown for reference, along with the Pearson’s R<sup>2</sup> value. These data demonstrate the precision of these measurements despite variations in the signal to noise that arises from variations in surface immunostaining intensity.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92406-fig4-figsupp1-v1.tif"/></fig></fig-group><p>Projecting the average relative intensities for the mutations at each residue onto the structure reveals that most positions exhibit similar trends in the mutational tolerance in each background, with loop residues being generally more permissive than those within TMDs (<xref ref-type="fig" rid="fig4">Figure 4D–F</xref>). Nevertheless, there are subdomains where the quantitative mutagenic effects deviate in a context-dependent manner. Variants bearing mutations within the C-terminal regions including ICL3, TMD6, and TMD7 fare consistently worse in the V276T background relative to WT (paired Wilcoxon signed rank test p-values of 0.0001, 0.02, and 0.005, respectively) (<xref ref-type="fig" rid="fig4">Figure 4B and E</xref>). Given that V276T perturbs the cotranslational membrane integration of TMD6 (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), this directional bias potentially suggests that the apparent interactions between these mutations manifest during the late stages of cotranslational folding. In contrast, mutations that are better tolerated in the context of W107A mGnRHR are located throughout the structure but are particularly abundant among residues in the middle of the primary structure that form ICL2, TMD4, and ECL2 (paired Wilcoxon signed rank test p-values of 0.0005, 0.0001, and 0.004, respectively) (<xref ref-type="fig" rid="fig4">Figure 4C and F</xref>). Together, these observations show how the proteostatic effects of mGnRHR mutations are modified by secondary mutations that differentially affect the fidelities of stage I and II folding.</p></sec><sec id="s2-3"><title>Distinct pairwise epistasis in V276T and W107A GnRHR</title><p>To compare epistatic trends in these libraries, we calculated epistasis scores (Ɛ) for the interactions that these 251 mutations form with V276T and W107A by comparing their relative effects on PME of the WT, V276T, and W107A variants using a previously described epistasis model (product model, see ‘Materials and methods’; <xref ref-type="bibr" rid="bib30">Olson et al., 2014</xref>). Positive Ɛ values denote double mutants that have greater PME than would be expected based on the effects of single mutants. Negative Ɛ values denote double mutants that have lower PME than would be expected based on the effects of single mutants. Pairs of mutations with Ɛ values near zero have additive effects on PME. For most double mutants, epistasis scores are near zero, suggesting that many of the 251 random mutations have additive effects on PME in each background. This result is consistent with evidence that epistatic interactions are typically rare in the context of stable proteins (<xref ref-type="bibr" rid="bib43">Starr and Thornton, 2016</xref>). Nevertheless, the distributions of epistasis scores for the two double mutant libraries are shifted in opposite directions. The mutations generally form positive epistatic interactions with W107A and negative epistatic interactions with V276T (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Interestingly, the difference in the epistasis scores for the interactions these variants form with W107A and V276T was at least 1.0 for 98 of the 251 variants (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). Notably, these 98 variants are enriched with TMD variants (65% TMD) relative to the overall set of 251 variants (45% TMD, Fisher’s exact test p=0.0019). These findings suggest random mutations form epistatic interactions in the context of unstable mGnRHR variants in a manner that depends on the specific folding defect (V276T vs. W107A) and topological context.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Epistasis in the mGnRHR double mutant libraries.</title><p>A histogram depicts the distribution of epistasis scores (Ɛ) for interactions the subset of 251 high-quality secondary mutations form with V276T (red) and W107A (blue).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92406-fig5-v1.tif"/></fig></sec><sec id="s2-4"><title>Molecular basis for the observed epistatic interactions</title><p>To identify general trends in the observed epistatic interactions, we utilized unsupervised learning to elucidate patterns among the relative PME values of variants across each genetic background. We first utilized uniform manifold approximation projection (UMAP) (<xref ref-type="bibr" rid="bib23">McInnes et al., 2018</xref>) to identify mutations that have similar expression profiles across these conditions. A projection of the variants onto a resulting two-dimensional coordinate reveals that most variants fall into one of approximately three groups (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Using a density-based hierarchical clustering analysis (HDBSCAN), we unambiguously assigned 182 variants into three distinct clusters based on their expression profiles alone (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>; <xref ref-type="bibr" rid="bib6">Campello et al., 2013</xref>). An analysis of the structural context of these mutants reveals that one of the largest clusters (cluster 3, n = 76) primarily consists of mutations of soluble loop residues that have little impact on expression and exhibit minimal epistasis (<xref ref-type="fig" rid="fig6">Figure 6A–C</xref>). This analysis also identified a smaller cluster of loop mutations (cluster 2, n = 30) that moderately decrease expression and exhibit a greater propensity to form epistatic interactions with V276T and/ or W107A relative to the neutral loop mutations in cluster 3 (<xref ref-type="fig" rid="fig6">Figure 6A–C</xref>). Nevertheless, most of the mutations that exhibit strong positive epistatic interactions with W107A fell into cluster 1 (n = 76), which primarily consists of mutations within TMDs that significantly decrease expression in all three genetic backgrounds (<xref ref-type="fig" rid="fig6">Figure 6A–C</xref>). A comparison across these clusters suggests positive epistatic interactions with W107A primarily stems from the fact that mutations that compromise expression can only cause a relatively modest reduction in the PME of W107A GnRHR (<xref ref-type="fig" rid="fig6">Figure 6B and C</xref>), which is already predominantly misfolded. In contrast, the moderately disruptive loop mutations in cluster 2 tend to exhibit more pronounced negative epistatic interactions with V276T than do the highly disruptive TMD mutations in cluster 1 (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). The divergent epistatic interactions that disruptive loop and TMD mutations form with V276T potentially arise from differences in the mechanistic basis for the destabilization caused by these two classes of mutations (see ‘Discussion’).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>General trends in mGnRHR epistasis.</title><p>Trends associated with the observed pairwise epistasis within mGnRHR are identified using unsupervised learning. (<bold>A</bold>) Uniform manifold approximation projection (UMAP) was used to differentiate variants based on differences in their relative expression in the V276T, W107A, or WT background. Variants are projected onto an arbitrary two-dimensional coordinate based on the results and are colored according to whether they were assigned to cluster 1 (green), cluster 2 (purple), cluster 3 (orange), or were designated as outliers (gray) by HDBSCAN. The percentage of the mutations that fall within transmembrane domains (TMDs) or loops are shown for reference. (<bold>B</bold>) A box and whisker plot depicts the statistical distributions of relative plasma membrane expression (PME) values among variants within each cluster in the context of V276T (red), W107A (blue), or WT (gray) mGnRHR. Select clusters of variants that exhibit statistically different expression profiles according to a Mann–Whitney <italic>U</italic>-test are indicated (*p&lt;0.001). A value of 1 corresponds to mutations that have no effect on the PME of mGnRHR in the indicated genetic background. (<bold>C</bold>) A box and whisker plot depicts the statistical distribution of epistasis scores associated with the interactions between the mutations within each cluster and either V276T (red) or W107A (blue). p-values for select Mann–Whitney <italic>U</italic>-tests comparing the interactions of these mutations with V276T and W107A are indicated. A value of 0 indicates that the effects of the two mutations are additive. (<bold>D</bold>) A box and whisker plot depicts the statistical distribution of Rosetta ΔΔG values among mutations within each cluster. p-values for select Mann–Whitney <italic>U</italic>-tests comparing the ΔΔG values across clusters are shown for reference. For panels (<bold>B–D</bold>), the edges of the boxes correspond to the 75th and 25th percentile values while the whiskers reflect the values of the 90th and 10th percentile. The central hash and square within the box represent the average and median values, respectively. These analyses were carried out on a subset of 243 variants with high-quality expression measurements with calculable Rosetta ΔΔG values.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92406-fig6-v1.tif"/></fig><p>Many epistatic interactions arise from the additive energetic effects of mutations on protein folding (<xref ref-type="bibr" rid="bib30">Olson et al., 2014</xref>; <xref ref-type="bibr" rid="bib47">Tokuriki and Tawfik, 2009</xref>). To determine how these trends relate to the effects of mutations on thermodynamic stability, we utilized Rosetta CM to generate structural models of 243 of the 251 variants that were scored in all three backgrounds and fall within the structured regions of the receptor (<xref ref-type="bibr" rid="bib42">Song et al., 2013</xref>). We then utilized a membrane-optimized Rosetta energy scoring function to approximate the change in the energy of the native structural ensemble of each variant (<xref ref-type="bibr" rid="bib1">Alford et al., 2015</xref>). The cluster of loop mutations with lower expression (cluster 2, avg. ΔΔG = +2.2 REU) generally contains more destabilizing mutations relative to the cluster of loop mutations with WT-like expression (cluster 3, avg. ΔΔG = +0.8 REU), which affirms the general relationship between stability and PME in this system (p=0.003, <xref ref-type="fig" rid="fig6">Figure 6B and D</xref>). However, the cluster of TMD variants (cluster 1, avg. ΔΔG = +3.4 REU) is generally more destabilizing than either of the loop clusters (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). A comparison across the clusters suggests that the degree of destabilization generally tracks with the magnitude of positive epistatic interactions that form with W107A, regardless of structural context (<xref ref-type="fig" rid="fig6">Figure 6C and D</xref>). This uptick in positive epistasis among mutations that destabilize the native fold and severely reduce PME likely reflects the attenuated effect of destabilizing mutations as the equilibrium fraction of folded protein approaches zero (see ‘Discussion<italic>’</italic>, <xref ref-type="fig" rid="fig7">Figure 7</xref>). In contrast to W107A, epistatic interactions with V276T are predominantly negative and are most pronounced among moderately destabilizing loop mutations (<xref ref-type="fig" rid="fig6">Figure 6C and D</xref>). The abundance of negative interactions with V276T parallels the observed pairwise epistasis in other folded proteins (<xref ref-type="bibr" rid="bib30">Olson et al., 2014</xref>), and likely reflects the higher baseline expression and/or stability of this variant relative to W107A (<xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig7">7</xref>). Nevertheless, stability-mediated epistasis cannot account for the attenuation of the epistatic interactions that V276T forms with the highly destabilizing mutations within cluster 1 relative to the moderately destabilizing mutations within cluster 2 (<xref ref-type="fig" rid="fig6">Figure 6C and D</xref>). These observations suggest that the magnitude of the epistatic interactions formed by V276T is dependent on not only the change in stability, but also the topological context of the secondary mutation.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Context-dependent impacts of stabilizing and destabilizing mutations.</title><p>Line plots depict the relationship between the equilibrium fraction of folded protein (<italic>f<sub>fold</sub></italic>) and the free energy of unfolding (ΔG<sub>unf</sub>). (<bold>A</bold>) A moderately stable protein (ΔG<sub>unf</sub> = +2 kcal/mol) exhibits a greater change in <italic>f<sub>fold</sub></italic> after acquiring one or more destabilizing mutations (total ΔΔG<sub>unf</sub> = –2 kcal/mol, red) than after acquiring one or more mutations that stabilize the protein to the same extent (total ΔΔG<sub>unf</sub> = +2 kcal/mol, blue). (<bold>B</bold>) A moderately unstable protein (ΔG<sub>unf</sub> = –2 kcal/mol) exhibits a greater change in <italic>f<sub>fold</sub></italic> after acquiring one or more stabilizing mutations (total ΔΔG<sub>unf</sub> = +2 kcal/mol, blue) than after acquiring one or more mutations that destabilize the protein to the same extent (total ΔΔG<sub>unf</sub> = –2 kcal/mol, red).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92406-fig7-v1.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Many epistatic interactions between mutations within genes encoding soluble proteins arise from their cumulative effects on protein folding energetics (<xref ref-type="bibr" rid="bib28">Nedrud et al., 2021</xref>; <xref ref-type="bibr" rid="bib30">Olson et al., 2014</xref>). Folded proteins can only tolerate a limited number of destabilizing mutations before their cumulative energetic effects cause a cooperative decrease in the fraction of folded protein (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Although this general principle should apply to all proteins, it is unclear how the distinct energetic processes involved in membrane protein biosynthesis and folding may alter such evolutionary couplings. In this study, we utilize DMS to compare the epistatic interactions formed by two mutations that reduce the expression of a misfolding-prone GPCR by selectively destabilizing either its cotranslational membrane integration (V276T) or its native tertiary structure (W107A). We note that the introduction of the V276T mutation into the mouse receptor utilized herein mimics one of the key destabilizing modifications that reduces the expression of hGnRHR relative to mGnRHR (<xref ref-type="bibr" rid="bib7">Chamness et al., 2021</xref>). Though the quantitative energetic effects of these mutations on cotranslational and/or post-translational folding processes remain unclear in the absence of a suitable biophysical assay, they each markedly reduce the plasma membrane expression of mGnRHR and it seems highly unlikely that they should elicit identical quantitative effects on folding and assembly (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Thus, a comparison of the epistatic interactions formed by these two mutations should reveal the extent to which the mechanism of misfolding impacts the propensity for genetic interactions between mutations. Through a focused analysis of 753 total single and double mutants, we find that these mutations give rise to divergent epistatic interactions that modify the PME of mGnRHR (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Mutations that form epistatic interactions with V276T tend to synergistically decrease mGnRHR expression (<xref ref-type="fig" rid="fig3">Figures 3A and B</xref> and <xref ref-type="fig" rid="fig4">4B, and</xref> <xref ref-type="fig" rid="fig5">5</xref>), a typical epistatic trend that likely arises from the combined destabilizing effects of both mutations. Surprisingly, these interactions are most prominent among moderately destabilizing loop mutations (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). In contrast, many of these same secondary mutations instead form positive epistatic interactions with W107A mGnRHR, regardless of their topological context (<xref ref-type="fig" rid="fig5">Figures 5</xref> and <xref ref-type="fig" rid="fig6">6C</xref>). As this comparison reflects the epistatic interactions formed by an identical set of secondary mutations, we conclude that these context-dependent epistatic interactions arise from differences in the magnitude and/or the mechanism of the mGnRHR destabilization caused by the V276T and W107A mutations. These observed trends potentially reflect a previously undescribed manifestation of ‘ensemble epistasis’ (<xref ref-type="bibr" rid="bib27">Morrison et al., 2021</xref>) in which genetic interactions arise from the differential effects of mutations on the accumulation of distinct misfolded conformations that vary with respect to their recognition and/or degradation by cellular quality control pathways.</p><p>In the context of stable proteins, stability-mediated epistasis tends to magnify the effects of deleterious mutations due to the cumulative destabilization that arises from sequential random substitutions (<xref ref-type="bibr" rid="bib46">Tokuriki et al., 2007</xref>). This is a fundamental consequence of the cooperative dependence of the fraction of folded protein on the free energy of unfolding. Indeed, most of the random mGnRHR mutations characterized herein are predicted to destabilize the native structure in a manner that coincides with a measurable decrease in the PME in the context of all three genetic backgrounds (<xref ref-type="fig" rid="fig4">Figures 4A</xref> and <xref ref-type="fig" rid="fig6">6D</xref>). Whereas these destabilizing mutations exhibit the expected negative epistatic couplings with V276T, their interactions with W107A skew positive (<xref ref-type="fig" rid="fig5">Figure 5</xref>). This anomalous positive epistasis is potentially a by-product of the severe destabilizing effects of W107A relative to V276T (<xref ref-type="fig" rid="fig2">Figure 2</xref>). While destabilizing secondary mutations can cause significant decreases in the yield of folded WT or V276T mGnRHR, the W107A variant already exhibits marginal surface immunostaining. In the context of this predominantly misfolded, poorly expressed variant, even highly destabilizing secondary mutations can only cause a relatively small decrease in the yield of folded protein. This observation can be more generally related to the relatively shallow dependence of the fraction of folded protein on the free energy of folding under conditions where folding becomes unfavorable – unfolding transitions become shallow as the fraction of folded protein approaches zero (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Stabilizing mutations can also generate potent positive epistatic couplings in this context given that even small increases in stability can push the system into the steepest portion of the transition zone (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Paradoxically, the asymmetry of the folding curve in this regime suggests destabilizing mutations are more tolerable in the context of an unstable protein – the effects of these variants exhibit ‘diminishing returns’ (<xref ref-type="bibr" rid="bib31">Otto and Feldman, 1997</xref>) because folding efficiency effectively has nowhere to go but upwards. Essentially, the nature of this sigmoidal transition suggests the typical trends associated with stability-mediated epistasis should become inverted as stability decreases. Such considerations could potentially expand the accessible sequence space in metastable proteins, which constitute a significant portion of the proteome (<xref ref-type="bibr" rid="bib12">Ghosh and Dill, 2010</xref>; <xref ref-type="bibr" rid="bib55">Zeldovich et al., 2007</xref>). Combinations of mutations that would not generally be tolerated in stable proteins may also occur through such mechanisms in the context of the numerous misfolded secondary alleles that are carried within the genomes of humans and other diploids with no appreciable fitness cost (e.g., the ΔF508 variant of <italic>CFTR</italic>).</p><p>Unlike W107A, the epistatic interactions formed by V276T appear to depend on their topological context- negative epistasis is more prevalent among moderately destabilizing loop variants than highly destabilizing TMD variants (<xref ref-type="fig" rid="fig6">Figure 6C and D</xref>). This observation suggests stability-mediated epistasis between mutations that destabilize the native tertiary structure of integral membrane proteins (stage II folding) may be distinct from the interactions that arise from the disruption of their translocon-mediated cotranslational membrane integration (stage I folding, <xref ref-type="fig" rid="fig1">Figure 1A</xref>). This divergence could potentially reflect the distinction between the energetic principles of protein folding relative to those that guide the insertion of proteins into membranes, which is fundamentally driven by a membrane depth-dependent solvation energetics (<xref ref-type="bibr" rid="bib16">Hessa et al., 2007</xref>; <xref ref-type="bibr" rid="bib26">Moon and Fleming, 2011</xref>). Counterintuitively, polar mutations that disrupt the membrane integration of individual TMDs also have the potential to form interhelical hydrogen bonds that can stabilize the topological orientation of neighboring TMDs, which can give rise to long-range topological couplings. (<xref ref-type="bibr" rid="bib14">Hermansson and von Heijne, 2003</xref>; <xref ref-type="bibr" rid="bib25">Meindl-Beinker et al., 2006</xref>; <xref ref-type="bibr" rid="bib29">Ojemalm et al., 2012</xref>). The propensity of such contacts to form may in some cases depend on the length and hydrophobicity of the loops that connect them (<xref ref-type="bibr" rid="bib52">Woodall et al., 2017</xref>). Finally, we should note that complex epistatic interactions between residues within TMDs could potentially arise through their propensity to remodel the translocon complex and/or other quality control interactions – polar residues within TMDs may affect the recruitment of secondary insertases and/or intramembrane chaperones such as TRAP, the PAT complex, the BOS complex, the GEL complex, and the ER membrane protein complex (<xref ref-type="bibr" rid="bib9">Chen et al., 2023</xref>; <xref ref-type="bibr" rid="bib11">Gemmer et al., 2023</xref>; <xref ref-type="bibr" rid="bib21">Matreyek et al., 2017</xref>; <xref ref-type="bibr" rid="bib34">Pleiner et al., 2020</xref>; <xref ref-type="bibr" rid="bib39">Shurtleff et al., 2018</xref>; <xref ref-type="bibr" rid="bib40">Smalinskaitė et al., 2022</xref>; <xref ref-type="bibr" rid="bib44">Sundaram et al., 2022</xref>). Additional insights into the mechanistic basis for the recruitment of such complexes may therefore be needed to fully rationalize evolutionary couplings between TMDs. We note that, more generally, we suspect that synergistic genetic interactions between mutations could potentially arise from changes in the energetics of many other biosynthetic processes such as cofactor binding, oligomer formation, and chaperone interactions (<xref ref-type="bibr" rid="bib4">Bershtein et al., 2013</xref>; <xref ref-type="bibr" rid="bib36">Rodrigues et al., 2016</xref>).</p><p>Together, our results reveal divergent, mechanism-dependent patterns of pairwise epistasis in the context of a misfolding-prone integral membrane protein. These findings suggest the folding-mediated epistasis is likely to vary among different classes of destabilizing mutations in a manner that should also depend on folding efficiency and/or the mechanism(s) of misfolding in the cell. These findings provide novel insights as to how the unique biosynthetic constraints of integral membrane proteins can potentially lead to unique evolutionary patterns. Moreover, our results generally suggest that the deleterious effects of destabilizing mutations are partially attenuated in the context of unstable proteins. Additional investigations are needed to explore how stability-mediated epistasis is modified by other proteostatic constraints, such as the interactions of nascent proteins with cofactors and/or molecular chaperones.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">GnRHR</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">L01119</td><td align="left" valign="bottom">-</td></tr><tr><td align="left" valign="bottom">Gene (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">GnRHR</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">L03380</td><td align="left" valign="bottom">-</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Escherichia coli</italic>)</td><td align="left" valign="bottom">NEB 10-β</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">C3020K</td><td align="left" valign="bottom">Electrocompetent</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">HEK293T</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">CRL-3216</td><td align="left" valign="bottom">-</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">Tet-Bxb1-BFP HEK293T</td><td align="left" valign="bottom">Laboratory of Doug Fowler</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">Clone 37 described in <xref ref-type="bibr" rid="bib19">Jones et al., 2020</xref><break/></td></tr><tr><td align="left" valign="bottom">Biological sample (<italic>Canis familiarus</italic>)</td><td align="left" valign="bottom">Pancreatic rough microsomes</td><td align="left" valign="bottom">tRNA probes</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">-</td></tr><tr><td align="left" valign="bottom">Biological sample (<italic>Oryctolagus cuniculus</italic>)</td><td align="left" valign="bottom">Reticulocyte lysate</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">L4960</td><td align="left" valign="bottom">Nuclease-treated</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Hemagglutinin Antibody (mouse monoclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="char" char="hyphen" valign="bottom">26183-D550</td><td align="left" valign="bottom">2–2.2.14, DyLight 550 conjugate</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pGEM- Lep- TMD6</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib16">Hessa et al., 2007</xref></td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">-</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pcDNA5 CMV-HA-mGnRHR-IRES-eGFP</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib7">Chamness et al., 2021</xref></td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">-</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pcDNA5 attB-HA-mGnRHR-IRES-eGFP</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">A plasmid described in <xref ref-type="bibr" rid="bib7">Chamness et al., 2021</xref> was further modified as is described in ‘Materials and methods’</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Custom mGnRHR primer pool</td><td align="left" valign="bottom">Agilent Technologies Inc</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">See <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for sequences</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Custom 10- base randomization primer</td><td align="left" valign="bottom">Integrated DNA Technologies</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom"><named-content content-type="sequence">gcatgaagaatctgcttagggttaggcgnnnnnnnnnncttcgcgatgtacgggccagat</named-content></td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">PrimeSTAR HS DNA Polymerase</td><td align="left" valign="bottom">Takara Bio Inc</td><td align="left" valign="bottom">R010B</td><td align="left" valign="bottom">-</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">KAPA HiFi HotStart Ready Mix</td><td align="left" valign="bottom">Roche Diagnostics</td><td align="char" char="." valign="bottom">07958927001</td><td align="left" valign="bottom">-</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">InFusion HD Cloning</td><td align="left" valign="bottom">Takara Bio Inc</td><td align="char" char="." valign="bottom">638944</td><td align="left" valign="bottom">-</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">GenElute Mammalian gDNA Miniprep Kit</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">G1N70</td><td align="left" valign="bottom">-</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Flowjo X</td><td align="left" valign="bottom">Treestar</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">-</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">OriginLab 2023</td><td align="left" valign="bottom">OriginLab</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">-</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Plasmid preparation and characterization of genetic libraries</title><p>The expression of transiently expressed single mutants was carried out using a previously described pcDNA5 FRT expression vector containing mGnRHR cDNA with an N-terminal hemagglutinin (HA) epitope and bicistronic eGFP (<xref ref-type="fig" rid="fig2">Figure 2</xref>; <xref ref-type="bibr" rid="bib7">Chamness et al., 2021</xref>). Mutations were introduced by site-directed mutagenesis with PrimeSTAR HS DNA Polymerase (Takara Bio, Shiga, Japan). Biochemical measurements of the membrane integration of TMD6 were carried out using a previously described pGEM vector containing modified leader peptidase (Lep), with TMDs of interest cloned into the H-segment (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>; <xref ref-type="bibr" rid="bib7">Chamness et al., 2021</xref>; <xref ref-type="bibr" rid="bib16">Hessa et al., 2007</xref>). Mutations were introduced into the H-segment by site-directed mutagenesis with PrimeSTAR HS DNA Polymerase (Takara Bio). Plasmids were purified using a ZymoPURE Midiprep Kit (Zymo Research, Irvine, CA). DMS experiments were carried out using a previously described pcDNA5 FRT vector containing mGnRHR cDNA bearing an N-terminal influenza hemagglutinin (HA) epitope, followed by an internal ribosome entry site (IRES) and eGFP sequence, which was further modified to be compatible with recombination-based DMS approaches (<xref ref-type="bibr" rid="bib7">Chamness et al., 2021</xref>). First, an attB recombination site was inserted in place of the CMV promoter by InFusion HD Cloning (Takara Bio). To facilitate the creation of these libraries using nicking mutagenesis, a BbvCI restriction site was introduced by site-directed mutagenesis using PrimeSTAR HS DNA Polymerase (Takara Bio). The V276T and W107A mutations were also introduced by site-directed mutagenesis with PrimeSTAR HS DNA Polymerase (Takara Bio).</p><p>To generate mutational libraries, a 10N UMI, or ‘barcode’, was first inserted into the plasmid backbone using a previously described nicking mutagenesis method (<xref ref-type="bibr" rid="bib53">Wrenbeck et al., 2016</xref>). Nicking mutagenesis plasmid products were transformed into NEB 10-beta electrocompetent cells (New England Biolabs, Ipswich, MA) and purified using a ZymoPURE Midiprep Kit (Zymo Research). A programmed oligo pool (Agilent, Santa Clara, CA) encoding all 19 amino acid substitutions at 85 residues throughout the mGnRHR sequence was then used to generate pools of single and double mutants in the context of WT, V276T, and W107A mGnRHR cDNA using a previously described nicking mutagenesis method (<xref ref-type="bibr" rid="bib24">Medina-Cucurella et al., 2019</xref>). The resulting plasmid products were transformed into NEB 10-beta electrocompetent cells (New England Biolabs) and purified using a ZymoPURE Midiprep Kit (Zymo Research). To limit the number of mGnRHR variants per UMI, these libraries were then bottlenecked through an additional transformation in NEB Turbo electrocompetent cells (New England Biolabs) and were again purified using a ZymoPURE Midiprep Kit (Zymo Research). The resulting plasmid preparations contained detectable levels of a concatemer product, which were removed from the mutational libraries by gel purification using a Zymoclean Gel DNA Recovery Kit (Zymo Research). Purified products were again transformed into either NEB 10-beta (New England Biolabs) or SIG10 (Sigma-Aldrich, St. Louis, MO) electrocompetent cells, and purified with a ZymoPURE Midiprep Kit (Zymo Research).</p><p>To associate each UMI with its corresponding GnRHR variant, the final plasmid libraries were also sequenced using PacBio SMRT sequencing. Briefly, plasmid libraries were first double-digested with PmlI and MfeI-HF restriction enzymes (New England Biolabs), then purified using a Zymo DNA Clean &amp; Concentrator-5 kit (Zymo Research). Complete digestion was verified by analyzing the products on an agarose gel, purity was assessed with a Synergy Neo2 microplate reader (BioTek, Winooski, VT), and the final yield was quantified using a Qubit4 fluorometer (Thermo Fisher, Waltham, MA). The 1537 bp fragment for each library, containing the 10N UMI and GnRHR open reading frame, was isolated on a BluePippin instrument (Sage Science, Beverly, MA). These fragments were then assembled into PacBio libraries and sequenced on the Sequel II system with a 30 hr runtime.</p><p>The sequence of each plasmid-derived fragment containing mGnRHR variants and their corresponding UMIs was determined by reconstructing the circular consensus sequences (CCS) for each independent well in the PacBio readout. mGnRHR libraries were sequenced to a depth of 1,825,010 wells for WT, 1,545,151 wells for V276T, and 1,497,359 wells for W107A. A minimum coverage of five passes around each circular fragment (subread) was required for incorporation of sequencing data from an individual well into the analysis. CCS were mapped to the reference open reading frame using minimap2. CCS that did not contain a complete 10-base UMI sequence or fully cover the target ORF were excluded from the analysis. Variations in the mGnRHR sequence of individual fragments were called using SAMtools. Reads were then grouped according to their UMI sequences. Given that insertion and deletion (indel) artifacts are prevalent within PacBio sequencing data, we only removed UMIs from the analysis if indels were detected at a specific position within the UMI in at least 10% of the subreads. Indels observed within the open-reading frame were only called if their occurrence was judged to be statistically significant relative to the background indel rate for the reads according to a binomial test (p≤0.05). Codon substitutions encoded in our primer library (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>) were called within the mGnRHR open-reading frame only if they were detected in at least 75% of the individual subreads. Only UMIs that were found to be associated with a single mGnRHR variant were included in the final analysis. Our final ‘dictionaries’ for the WT, V276T, and W107A libraries contained 3,261, 531, and 4962 unique UMIs, respectively, that could be indexed to a corresponding mGnRHR variant.</p></sec><sec id="s4-2"><title>Preparation of cellular libraries and cell sorting</title><p>A previously described HEK293T cell line with a genomic Tet-Bxb1-BFP landing pad was obtained from D. Fowler (<xref ref-type="bibr" rid="bib21">Matreyek et al., 2017</xref>). Short tandem repeat profiling was carried out to confirm that these cells are derived from HEK293T cells and PCR-based mycoplasma testing was carried out to ensure cultures were not contaminated (American Type Culture Collection, Manassas, VA). Cells were grown at 37°C and 5.0% CO<sub>2</sub> in complete media, made of Dulbecco’s Modified Eagle’s medium (DMEM, Gibco, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS, Gibco), 0.5% penicillin (Gibco), and 0.5% streptomycin (Gibco). Two million cells were plated in 10 cm tissue culture plates and co-transfected the next day with 475 ng of plasmid encoding bxb1 recombinase and 7125 ng of the plasmid library using Lipofectamine 3000 (Invitrogen). Cells were grown at 33°C for 4 days after transfection. Two days after transfection, the cells were induced with 2 µg/mL doxycycline. All cells were expanded into 15 cm tissue culture plates 6 days after transfection, and 10 million cells were re-plated into new 15 cm tissue culture plates 3 days later.</p><p>Twelve days after transfection, the cells were washed with 1× phosphate-buffered saline (PBS, Gibco) and harvested with TrypLE Express protease (Gibco). Cells were washed twice with 2% fetal bovine serum in PBS (wash buffer), resuspended in PBS containing 2% FBS to 10 M cells/mL, and then sorted on a BD FACS Aria II (BD Biosciences, Franklin Lakes, NJ). Recombined cells were isolated based on their characteristic gain of bicistronic eGFP and loss of BFP expression (<xref ref-type="bibr" rid="bib21">Matreyek et al., 2017</xref>). Forward and side scatter profiles were first used to gate for intact live cells, and cells with eGFP-positive (488 nm laser, 530/30 nm emission filter) and BFP-negative (405 nm laser, 450/50 nm emission filter) fluorescence profiles were collected in complete media supplemented with 10% FBS (Gibco) and then plated in 10 cm tissue culture plates. Cells were induced with 2 µg/mL doxycycline 24 hr after sorting. Four days after sorting, 10 million cells were passaged into 15 cm tissue culture plates.</p><p>Seven days after sorting for eGFP-positive cells, cells were sorted again according to the surface expression of GnRHR variants. Briefly, cells were first washed with 1× PBS (Gibco) and harvested with TrypLE Express protease (Gibco). GnRHRs expressed at the cell surface were immunostained for 30 min in the dark with DyLight 550-conjugated anti-HA antibody (Invitrogen). Cells were then washed twice with PBS containing 2% FBS, and sorted on a BD FACS Aria II (BD Biosciences). Forward and side scatter profiles were used to gate for intact live cells, and eGFP fluorescence was used to gate for recombined cells. Cells were then sorted into even quartiles based on the amount of DyLight 550 fluorescence (561 nm laser, 585/15 nm emission filter). Sorted cells were collected in complete media supplemented with 10% FBS (Gibco) and plated in 10 cm tissue culture plates. Cells were allowed to grow to confluency and then were washed with 1 X PBS (Gibco) and harvested with TrypLE Express protease (Gibco). Cell pellets were frozen for subsequent analysis.</p></sec><sec id="s4-3"><title>Extraction of genomic DNA and next-generation sequencing</title><p>Genomic DNA (gDNA) was extracted from cell pellets using the Sigma GenElute Mammalian gDNA Miniprep Kit (Sigma-Aldrich). DNA amplicons for Illumina sequencing were produced from the gDNA using a previously described semi-nested polymerase chain reaction (PCR) technique (<xref ref-type="bibr" rid="bib21">Matreyek et al., 2017</xref>). In order to selectively amplify recombined DNA, the first PCR utilized a primer which anneals upstream of the 10N UMI and a primer that anneals in the BFP-encoding region of the landing pad. Eight replicate PCRs were carried out with 2.5 µg of gDNA and HiFi HotStart Ready Mix (Kapa Biosystems, Wilmington, MA). These PCRs were limited to seven cycles to avoid PCR bias. PCR products were purified using a ZR-96 DNA Clean &amp; Concentrator-5 kit (Zymo Research), and replicate products were then pooled. 10 µL of this first PCR product was then used as the template for a second PCR, which utilized primers that incorporate Illumina adapter sequences to both ends of the 10N UMI. To avoid PCR bias, these reactions were monitored by real-time PCR on a StepOne RT-PCR instrument (Applied Biosystems, Waltham, MA) and terminated during mid-log amplification (17 or 18 cycles). Four replicate PCRs were carried out with HiFi HotStart Ready Mix (Kapa Biosystems) and SYBR Green fluorescent dye (Applied Biosystems). Replicate PCR products were then combined and purified with a Zymoclean Gel DNA Recovery Kit (Zymo Research). To further improve the yield and quality of the amplicons, an additional six-cycle PCR was carried out with the HiFi HotStart Ready Mix (Kapa Biosystems) and primers that preserve the DNA sequence. These PCR products were then purified using a Zymo DNA Clean &amp; Concentrator-5 kit (Zymo Research). Finally, amplicon yield and quality were assessed using an Agilent 2200 TapeStation with D1000 tape (Agilent Technologies, Santa Clara, CA) and a Synergy Neo2 microplate reader (BioTek). Amplicons were sequenced using an Illumina NextSeq150 flow cell, paired end, with 50% PhiX content.</p></sec><sec id="s4-4"><title>Plasma membrane expression and epistasis measurements</title><p>Illumina sequencing of the recombined UMIs within each sorted cell fraction were matched to the corresponding GnRHR mutants using the PacBio sequencing data and subjected to previously described quality filtering (<xref ref-type="bibr" rid="bib32">Penn et al., 2020</xref>). Estimations of PME for each mutant were then calculated as previously described (<xref ref-type="bibr" rid="bib32">Penn et al., 2020</xref>). PME measurements were averaged across two biological replicates. Within each library, the average fluorescence intensity values of the mutants were ranked and converted into a percentile. Mutants that differed in their percentile values by more than 25% across the two replicates were excluded from analysis. The use of percentile-based filtering overcomes intrinsic limitations associated with the distinct dynamic range constraints that occur because of the distinct surface immunostaining profiles of these three cellular libraries (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Intensity values that meet these criteria are highly correlated across the two biological replicates (average Spearman’s ρ = 0.936 across the three libraries, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). To facilitate the comparison of epistatic interactions within a common set of secondary mutations, we excluded mutants that did not pass quality filtering in all three libraries from our analysis. After data filtering, we obtained PME measurements for 251 mutants in all three libraries (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). These PME measurements were then utilized to calculate epistasis scores for the double mutants in the V276T and W107A libraries using the following equation:<disp-formula id="equ1"><mml:math id="m1"><mml:mrow><mml:mi>ε</mml:mi><mml:mo>=</mml:mo><mml:mi>l</mml:mi><mml:mi>n</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>ω</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:mi>l</mml:mi><mml:mi>n</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>ω</mml:mi><mml:mrow><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:mi>l</mml:mi><mml:mi>n</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>ω</mml:mi><mml:mrow><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>where <italic>Ɛ</italic> is the epistasis score, ω<italic><sub>ab</sub></italic> is the fluorescence intensity of the double mutant relative to WT mGnRHR, ω<italic><sub>a</sub></italic> is the fluorescence intensity of the single mutant in the WT library relative to WT mGnRHR, and ω<italic><sub>b</sub></italic> is the fluorescence intensity of the background mutation (either V276T or W107A) relative to WT mGnRHR, as previously described (<xref ref-type="bibr" rid="bib30">Olson et al., 2014</xref>).</p></sec><sec id="s4-5"><title>Expression measurements of individual GnRHR variants</title><p>HEK283T cells were obtained from ATCC and grown under the same conditions described above. GnRHR variants were transiently expressed in these cells, and the plasma membrane and intracellular expression of these variants was measured by flow cytometry, as previously described (<xref ref-type="bibr" rid="bib7">Chamness et al., 2021</xref>). The reported expression levels represent measurements from three biological replicates.</p></sec><sec id="s4-6"><title>In vitro translation of chimeric Lep proteins</title><p>Messenger RNA (mRNA) of chimeric Lep proteins was generated and used for in vitro translation reactions as previously described (<xref ref-type="bibr" rid="bib7">Chamness et al., 2021</xref>). Translation products were then analyzed by SDS-PAGE as previously described (<xref ref-type="bibr" rid="bib7">Chamness et al., 2021</xref>). The intensities of singly (<italic>G</italic>1) and doubly (<italic>G</italic>2) glycosylated protein were quantified by densitometry in ImageJ software. Apparent transfer free energy values representing transfer of the TMDs of interest from the translocon to the membrane were then calculated using the following equation:<disp-formula id="equ2"><mml:math id="m2"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:msub><mml:mi>G</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>p</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>l</mml:mi><mml:mi>n</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>p</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>l</mml:mi><mml:mi>n</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:mi>G</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>G</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>where <italic>ΔG<sub>app</sub></italic> is the free energy for transfer of the TMD into the membrane, <italic>R</italic> is the universal gas constant, <italic>T</italic> is the temperature, <italic>K<sub>app</sub></italic> is the equilibrium constant for transfer of the TMD into the membrane, <italic>G</italic>1 is the intensity of the singly glycosylated band, and <italic>G</italic>2 is the intensity of the doubly glycosylated band, as previously described (<xref ref-type="bibr" rid="bib15">Hessa et al., 2005</xref>). The reported transfer free energy values represent the average of three experimental replicates.</p></sec><sec id="s4-7"><title>Structural modeling of <italic>Mus musculus</italic> GnRHR</title><p>The sequence of mGnRHR was obtained from UniProt (accession number Q01776) and a homology model in the inactive state was generated as previously described (<xref ref-type="bibr" rid="bib7">Chamness et al., 2021</xref>). Images were generated by structurally aligning this mGnRHR model to an experimentally determined inactive-state human GnRHR crystal structure (GNRHR, PDB 7BR3, 2.79 Å) using the Super command in PyMol (Schrödinger, Inc, New York, NY) (<xref ref-type="bibr" rid="bib54">Yan et al., 2020</xref>).</p></sec><sec id="s4-8"><title>Computational estimates for the stability of mGnRHR variants</title><p>Structural estimates for the effects of mutations on the stability of mGnRHR were determined using a previously described Rosetta based protocol featuring a membrane protein optimized energy function (<xref ref-type="bibr" rid="bib1">Alford et al., 2015</xref>; <xref ref-type="bibr" rid="bib2">Barlow et al., 2018</xref>). Briefly, the homology model of mGnRHR described above was used as the starting structure for computational stability estimates. A spanfile describing the transmembrane regions was created for mGnRHR using OCTOPUS predictions from Topcons (<xref ref-type="bibr" rid="bib3">Bernsel et al., 2009</xref>; <xref ref-type="bibr" rid="bib49">Viklund and Elofsson, 2008</xref>). The homology model was transformed into membrane coordinates using the mp_transform application. An ensemble of structures of each variant and wildtype (50 iterations) was generated from the homology model. For variants containing two mutations, the mutations were both introduced at the same time. The ΔΔG for each variant was calculated by subtracting the average score of the three lowest scoring variant models from the average score of the three lowest scoring WT models (ΔΔG = ΔG<sub>mut</sub> - ΔG<sub>wt</sub>).</p></sec><sec id="s4-9"><title>Unsupervised learning</title><p>To classify mGnRHR variants based on their expression profiles, we first standardized their scores using the Standard Scaler tool from Python’s scikit-learn library in order to ensure that the clustering algorithms are not affected by the scale of the data. Next, we then reduced the dimensionality of the standardized data using UMAP (<xref ref-type="bibr" rid="bib23">McInnes et al., 2018</xref>). We then used a density-based clustering algorithm (HDBSCAN) to cluster variants based on their expression profiles (<xref ref-type="bibr" rid="bib22">McInnes et al., 2017</xref>). Unsupervised learning analyses were carried out based on deep mutational scanning measurements alone and did not incorporate any structural and/ or energetic parameters.</p></sec><sec id="s4-10"><title>Quantification and analysis</title><p>Flow cytometry data were analyzed in FlowJo software (Treestar, Ashland, OR), and in vitro translation data were analyzed in ImageJ software. PME measurements were analyzed in Origin software (OriginLab, Northampton, MA) and mapped onto the mGnRHR homology model in PyMol (Schrödinger, Inc).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Software, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Validation, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Formal analysis, Methodology, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Software, Formal analysis, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Data curation, Formal analysis, Validation, Methodology, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Data curation, Software, Formal analysis, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Software, Supervision, Funding acquisition, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-92406-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Predicted and measured apparent transfer free energies of mGnRHR TM6.</title></caption><media xlink:href="elife-92406-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Solvent accessible surface area of mGnRHR residues.</title></caption><media xlink:href="elife-92406-supp2-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>mGnRHR library mutants with associated oligo sequences.</title></caption><media xlink:href="elife-92406-supp3-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Deep mutational scanning measurements, epistasis scores, and cluster identities.</title></caption><media xlink:href="elife-92406-supp4-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Code for the analysis of sequencing data for deep mutational scanning experiments can be found on the <ext-link ext-link-type="uri" xlink:href="https://github.com/schebachlab/gnrhr_epistasis_dms">Schlebach Lab GitHub page</ext-link> (copy archived at <xref ref-type="bibr" rid="bib8">Chamness et al., 2024</xref>). Illumina and PacBio sequencing data is freely available through <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1062836">NCBI</ext-link>. Fluorescence intensity values for mutants in all three mutational libraries are included as Excel files in the Supplementary Materials.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Charmness</surname><given-names>LR</given-names></name><name><surname>Kuntz</surname><given-names>CP</given-names></name><name><surname>McKee</surname><given-names>AG</given-names></name><name><surname>Penn</surname><given-names>WD</given-names></name><name><surname>Hemmerich</surname><given-names>CM</given-names></name><name><surname>Rusch</surname><given-names>DB</given-names></name><name><surname>Woods</surname><given-names>H</given-names></name><name><surname>Meiler</surname><given-names>J</given-names></name><name><surname>Schelbach</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Divergent Folding-Mediated Epistasis in the Context of Unstable Membrane Protein Variants</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1062836">PRJNA1062836</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Christiane Hassel and the Indiana University Bloomington Flow Cytometry Core Facility, as well as Luke Tallon, Xuechu Zhao, Lisa Sadzewicz, and the University of Maryland Institute for Genome Sciences for their experimental support. This work was supported by a National Science Foundation (NSF) Graduate Research Fellowship (1342962 to LMC) and by the National Institutes of Health (R01GM129261 to JPS). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the NSF.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alford</surname><given-names>RF</given-names></name><name><surname>Koehler Leman</surname><given-names>J</given-names></name><name><surname>Weitzner</surname><given-names>BD</given-names></name><name><surname>Duran</surname><given-names>AM</given-names></name><name><surname>Tilley</surname><given-names>DC</given-names></name><name><surname>Elazar</surname><given-names>A</given-names></name><name><surname>Gray</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>An integrated framework advancing membrane protein modeling and design</article-title><source>PLOS Computational Biology</source><volume>11</volume><elocation-id>e1004398</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004398</pub-id><pub-id pub-id-type="pmid">26325167</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barlow</surname><given-names>KA</given-names></name><name><surname>Ó Conchúir</surname><given-names>S</given-names></name><name><surname>Thompson</surname><given-names>S</given-names></name><name><surname>Suresh</surname><given-names>P</given-names></name><name><surname>Lucas</surname><given-names>JE</given-names></name><name><surname>Heinonen</surname><given-names>M</given-names></name><name><surname>Kortemme</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Flex ddG: rosetta ensemble-based estimation of changes in protein-protein binding affinity upon mutation</article-title><source>The Journal of Physical Chemistry. B</source><volume>122</volume><fpage>5389</fpage><lpage>5399</lpage><pub-id pub-id-type="doi">10.1021/acs.jpcb.7b11367</pub-id><pub-id pub-id-type="pmid">29401388</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernsel</surname><given-names>A</given-names></name><name><surname>Viklund</surname><given-names>H</given-names></name><name><surname>Hennerdal</surname><given-names>A</given-names></name><name><surname>Elofsson</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>TOPCONS: consensus prediction of membrane protein topology</article-title><source>Nucleic Acids Research</source><volume>37</volume><fpage>W465</fpage><lpage>W468</lpage><pub-id pub-id-type="doi">10.1093/nar/gkp363</pub-id><pub-id pub-id-type="pmid">19429891</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bershtein</surname><given-names>S</given-names></name><name><surname>Mu</surname><given-names>W</given-names></name><name><surname>Serohijos</surname><given-names>AWR</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Shakhnovich</surname><given-names>EI</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Protein quality control acts on folding intermediates to shape the effects of mutations on organismal fitness</article-title><source>Molecular Cell</source><volume>49</volume><fpage>133</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2012.11.004</pub-id><pub-id pub-id-type="pmid">23219534</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>JD</given-names></name><name><surname>Raval</surname><given-names>A</given-names></name><name><surname>Wilke</surname><given-names>CO</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Thermodynamics of neutral protein evolution</article-title><source>Genetics</source><volume>175</volume><fpage>255</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1534/genetics.106.061754</pub-id><pub-id pub-id-type="pmid">17110496</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Campello</surname><given-names>R</given-names></name><name><surname>Moulavi</surname><given-names>D</given-names></name><name><surname>Sander</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><source>Density-Based Clustering Based on Hierarchical Density Estimates in: Advances in Knowledge Discovery and Data Mining</source><publisher-name>Springer</publisher-name><pub-id pub-id-type="doi">10.1007/978-3-642-37456-2</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamness</surname><given-names>LM</given-names></name><name><surname>Zelt</surname><given-names>NB</given-names></name><name><surname>Harrington</surname><given-names>HR</given-names></name><name><surname>Kuntz</surname><given-names>CP</given-names></name><name><surname>Bender</surname><given-names>BJ</given-names></name><name><surname>Penn</surname><given-names>WD</given-names></name><name><surname>Ziarek</surname><given-names>JJ</given-names></name><name><surname>Meiler</surname><given-names>J</given-names></name><name><surname>Schlebach</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Molecular basis for the evolved instability of a human G-protein coupled receptor</article-title><source>Cell Reports</source><volume>37</volume><elocation-id>110046</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.110046</pub-id><pub-id pub-id-type="pmid">34818554</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Chamness</surname><given-names>LM</given-names></name><name><surname>Kuntz</surname><given-names>CP</given-names></name><name><surname>McKee</surname><given-names>AG</given-names></name><name><surname>Penn</surname><given-names>WD</given-names></name><name><surname>Hemmerich</surname><given-names>CM</given-names></name><name><surname>Rusch</surname><given-names>DB</given-names></name><name><surname>Woods</surname><given-names>H</given-names></name><name><surname>Meiler</surname><given-names>J</given-names></name><name><surname>Schlebach</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Gnrhr_epistasis_dms</data-title><version designator="swh:1:rev:e1a7192e537abe86c1e04320b910d79329cbe487">swh:1:rev:e1a7192e537abe86c1e04320b910d79329cbe487</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:f4094bf83ef7908a0a73c6c29a4152187322f8fc;origin=https://github.com/schebachlab/gnrhr_epistasis_dms;visit=swh:1:snp:adba72f0fb44790b23d07f6f5d93e2a4e2985498;anchor=swh:1:rev:e1a7192e537abe86c1e04320b910d79329cbe487">https://archive.softwareheritage.org/swh:1:dir:f4094bf83ef7908a0a73c6c29a4152187322f8fc;origin=https://github.com/schebachlab/gnrhr_epistasis_dms;visit=swh:1:snp:adba72f0fb44790b23d07f6f5d93e2a4e2985498;anchor=swh:1:rev:e1a7192e537abe86c1e04320b910d79329cbe487</ext-link></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Mondal</surname><given-names>A</given-names></name><name><surname>Abderemane-Ali</surname><given-names>F</given-names></name><name><surname>Jang</surname><given-names>S</given-names></name><name><surname>Niranjan</surname><given-names>S</given-names></name><name><surname>Montaño</surname><given-names>JL</given-names></name><name><surname>Zaro</surname><given-names>BW</given-names></name><name><surname>Minor</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>EMC chaperone–CaV structure reveals an ionchannel assembly intermediate</article-title><source>Nature</source><volume>619</volume><fpage>410</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1038/s41586-023-06175-5</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faber</surname><given-names>MS</given-names></name><name><surname>Wrenbeck</surname><given-names>EE</given-names></name><name><surname>Azouz</surname><given-names>LR</given-names></name><name><surname>Steiner</surname><given-names>PJ</given-names></name><name><surname>Whitehead</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Impact of in vivo protein folding probability on local fitness landscapes</article-title><source>Molecular Biology and Evolution</source><volume>36</volume><fpage>2764</fpage><lpage>2777</lpage><pub-id pub-id-type="doi">10.1093/molbev/msz184</pub-id><pub-id pub-id-type="pmid">31400199</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gemmer</surname><given-names>M</given-names></name><name><surname>Chaillet</surname><given-names>ML</given-names></name><name><surname>van Loenhout</surname><given-names>J</given-names></name><name><surname>Cuevas Arenas</surname><given-names>R</given-names></name><name><surname>Vismpas</surname><given-names>D</given-names></name><name><surname>Gröllers-Mulderij</surname><given-names>M</given-names></name><name><surname>Koh</surname><given-names>FA</given-names></name><name><surname>Albanese</surname><given-names>P</given-names></name><name><surname>Scheltema</surname><given-names>RA</given-names></name><name><surname>Howes</surname><given-names>SC</given-names></name><name><surname>Kotecha</surname><given-names>A</given-names></name><name><surname>Fedry</surname><given-names>J</given-names></name><name><surname>Förster</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Visualization of translation and protein biogenesis at the ER membrane</article-title><source>Nature</source><volume>614</volume><fpage>160</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-05638-5</pub-id><pub-id pub-id-type="pmid">36697828</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>K</given-names></name><name><surname>Dill</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cellular proteomes have broad distributions of protein stability</article-title><source>Biophysical Journal</source><volume>99</volume><fpage>3996</fpage><lpage>4002</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2010.10.036</pub-id><pub-id pub-id-type="pmid">21156142</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>LI</given-names></name><name><surname>Suchard</surname><given-names>MA</given-names></name><name><surname>Bloom</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Stability-mediated epistasis constrains the evolution of an influenza protein</article-title><source>eLife</source><volume>2</volume><elocation-id>e00631</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.00631</pub-id><pub-id pub-id-type="pmid">23682315</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermansson</surname><given-names>M</given-names></name><name><surname>von Heijne</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Inter-helical hydrogen bond formation during membrane protein integration into the ER membrane</article-title><source>Journal of Molecular Biology</source><volume>334</volume><fpage>803</fpage><lpage>809</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2003.10.019</pub-id><pub-id pub-id-type="pmid">14636604</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hessa</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Bihlmaier</surname><given-names>K</given-names></name><name><surname>Lundin</surname><given-names>C</given-names></name><name><surname>Boekel</surname><given-names>J</given-names></name><name><surname>Andersson</surname><given-names>H</given-names></name><name><surname>Nilsson</surname><given-names>I</given-names></name><name><surname>White</surname><given-names>SH</given-names></name><name><surname>von Heijne</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Recognition of transmembrane helices by the endoplasmic reticulum translocon</article-title><source>Nature</source><volume>433</volume><fpage>377</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1038/nature03216</pub-id><pub-id pub-id-type="pmid">15674282</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hessa</surname><given-names>T</given-names></name><name><surname>Meindl-Beinker</surname><given-names>NM</given-names></name><name><surname>Bernsel</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Lerch-Bader</surname><given-names>M</given-names></name><name><surname>Nilsson</surname><given-names>I</given-names></name><name><surname>White</surname><given-names>SH</given-names></name><name><surname>von Heijne</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Molecular code for transmembrane-helix recognition by the Sec61 translocon</article-title><source>Nature</source><volume>450</volume><fpage>1026</fpage><lpage>1030</lpage><pub-id pub-id-type="doi">10.1038/nature06387</pub-id><pub-id pub-id-type="pmid">18075582</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janovick</surname><given-names>JA</given-names></name><name><surname>Knollman</surname><given-names>PE</given-names></name><name><surname>Brothers</surname><given-names>SP</given-names></name><name><surname>Ayala-Yáñez</surname><given-names>R</given-names></name><name><surname>Aziz</surname><given-names>AS</given-names></name><name><surname>Conn</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Regulation of G protein-coupled receptor trafficking by inefficient plasma membrane expression: molecular basis of an evolved strategy</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>8417</fpage><lpage>8425</lpage><pub-id pub-id-type="doi">10.1074/jbc.M510601200</pub-id><pub-id pub-id-type="pmid">16446355</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janovick</surname><given-names>JA</given-names></name><name><surname>Stewart</surname><given-names>MD</given-names></name><name><surname>Jacob</surname><given-names>D</given-names></name><name><surname>Martin</surname><given-names>LD</given-names></name><name><surname>Deng</surname><given-names>JM</given-names></name><name><surname>Stewart</surname><given-names>CA</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Cornea</surname><given-names>A</given-names></name><name><surname>Chavali</surname><given-names>L</given-names></name><name><surname>Lopez</surname><given-names>S</given-names></name><name><surname>Mitalipov</surname><given-names>S</given-names></name><name><surname>Kang</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Manna</surname><given-names>PR</given-names></name><name><surname>Stocco</surname><given-names>DM</given-names></name><name><surname>Behringer</surname><given-names>RR</given-names></name><name><surname>Conn</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Restoration of testis function in hypogonadotropic hypogonadal mice harboring a misfolded GnRHR mutant by pharmacoperone drug therapy</article-title><source>PNAS</source><volume>110</volume><fpage>21030</fpage><lpage>21035</lpage><pub-id pub-id-type="doi">10.1073/pnas.1315194110</pub-id><pub-id pub-id-type="pmid">24324164</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>EM</given-names></name><name><surname>Lubock</surname><given-names>NB</given-names></name><name><surname>Venkatakrishnan</surname><given-names>AJ</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Tseng</surname><given-names>AM</given-names></name><name><surname>Paggi</surname><given-names>JM</given-names></name><name><surname>Latorraca</surname><given-names>NR</given-names></name><name><surname>Cancilla</surname><given-names>D</given-names></name><name><surname>Satyadi</surname><given-names>M</given-names></name><name><surname>Davis</surname><given-names>JE</given-names></name><name><surname>Babu</surname><given-names>MM</given-names></name><name><surname>Dror</surname><given-names>RO</given-names></name><name><surname>Kosuri</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Structural and functional characterization of G protein-coupled receptors with deep mutational scanning</article-title><source>eLife</source><volume>9</volume><elocation-id>e54895</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.54895</pub-id><pub-id pub-id-type="pmid">33084570</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marinko</surname><given-names>JT</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Penn</surname><given-names>WD</given-names></name><name><surname>Capra</surname><given-names>JA</given-names></name><name><surname>Schlebach</surname><given-names>JP</given-names></name><name><surname>Sanders</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Folding and misfolding of human membrane proteins in health and disease: from single molecules to cellular proteostasis</article-title><source>Chemical Reviews</source><volume>119</volume><fpage>5537</fpage><lpage>5606</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.8b00532</pub-id><pub-id pub-id-type="pmid">30608666</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matreyek</surname><given-names>KA</given-names></name><name><surname>Stephany</surname><given-names>JJ</given-names></name><name><surname>Fowler</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A platform for functional assessment of large variant libraries in mammalian cells</article-title><source>Nucleic Acids Research</source><volume>45</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx183</pub-id><pub-id pub-id-type="pmid">28335006</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McInnes</surname><given-names>L</given-names></name><name><surname>Healy</surname><given-names>J</given-names></name><name><surname>Astels</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>hdbscan: hierarchical density based clustering</article-title><source>The Journal of Open Source Software</source><volume>2</volume><elocation-id>205</elocation-id><pub-id pub-id-type="doi">10.21105/joss.00205</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McInnes</surname><given-names>L</given-names></name><name><surname>Healy</surname><given-names>J</given-names></name><name><surname>Saul</surname><given-names>N</given-names></name><name><surname>Großberger</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>UMAP: uniform manifold approximation and projection</article-title><source>Journal of Open Source Software</source><volume>3</volume><elocation-id>861</elocation-id><pub-id pub-id-type="doi">10.21105/joss.00861</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina-Cucurella</surname><given-names>AV</given-names></name><name><surname>Steiner</surname><given-names>PJ</given-names></name><name><surname>Faber</surname><given-names>MS</given-names></name><name><surname>Beltrán</surname><given-names>J</given-names></name><name><surname>Borelli</surname><given-names>AN</given-names></name><name><surname>Kirby</surname><given-names>MB</given-names></name><name><surname>Cutler</surname><given-names>SR</given-names></name><name><surname>Whitehead</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>User-defined single pot mutagenesis using unamplified oligo pools</article-title><source>Protein Engineering, Design and Selection</source><volume>32</volume><fpage>41</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1093/protein/gzz013</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meindl-Beinker</surname><given-names>NM</given-names></name><name><surname>Lundin</surname><given-names>C</given-names></name><name><surname>Nilsson</surname><given-names>I</given-names></name><name><surname>White</surname><given-names>SH</given-names></name><name><surname>von Heijne</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Asn- and Asp-mediated interactions between transmembrane helices during translocon-mediated membrane protein assembly</article-title><source>EMBO Reports</source><volume>7</volume><fpage>1111</fpage><lpage>1116</lpage><pub-id pub-id-type="doi">10.1038/sj.embor.7400818</pub-id><pub-id pub-id-type="pmid">17008929</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname><given-names>CP</given-names></name><name><surname>Fleming</surname><given-names>KG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Side-chain hydrophobicity scale derived from transmembrane protein folding into lipid bilayers</article-title><source>PNAS</source><volume>108</volume><fpage>10174</fpage><lpage>10177</lpage><pub-id pub-id-type="doi">10.1073/pnas.1103979108</pub-id><pub-id pub-id-type="pmid">21606332</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrison</surname><given-names>AJ</given-names></name><name><surname>Wonderlick</surname><given-names>DR</given-names></name><name><surname>Harms</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Ensemble epistasis: thermodynamic origins of nonadditivity between mutations</article-title><source>Genetics</source><volume>219</volume><elocation-id>iyab105</elocation-id><pub-id pub-id-type="doi">10.1093/genetics/iyab105</pub-id><pub-id pub-id-type="pmid">34849909</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nedrud</surname><given-names>D</given-names></name><name><surname>Coyote-Maestas</surname><given-names>W</given-names></name><name><surname>Schmidt</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A large-scale survey of pairwise epistasis reveals a mechanism for evolutionary expansion and specialization of PDZ domains</article-title><source>Proteins</source><volume>89</volume><fpage>899</fpage><lpage>914</lpage><pub-id pub-id-type="doi">10.1002/prot.26067</pub-id><pub-id pub-id-type="pmid">33620761</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ojemalm</surname><given-names>K</given-names></name><name><surname>Halling</surname><given-names>KK</given-names></name><name><surname>Nilsson</surname><given-names>I</given-names></name><name><surname>von Heijne</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Orientational preferences of neighboring helices can drive ER insertion of a marginally hydrophobic transmembrane helix</article-title><source>Molecular Cell</source><volume>45</volume><fpage>529</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2011.12.024</pub-id><pub-id pub-id-type="pmid">22281052</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname><given-names>CA</given-names></name><name><surname>Wu</surname><given-names>NC</given-names></name><name><surname>Sun</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A comprehensive biophysical description of pairwise epistasis throughout an entire protein domain</article-title><source>Current Biology</source><volume>24</volume><fpage>2643</fpage><lpage>2651</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2014.09.072</pub-id><pub-id pub-id-type="pmid">25455030</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otto</surname><given-names>SP</given-names></name><name><surname>Feldman</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Deleterious mutations, variable epistatic interactions, and the evolution of recombination</article-title><source>Theoretical Population Biology</source><volume>51</volume><fpage>134</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1006/tpbi.1997.1301</pub-id><pub-id pub-id-type="pmid">9169238</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penn</surname><given-names>WD</given-names></name><name><surname>McKee</surname><given-names>AG</given-names></name><name><surname>Kuntz</surname><given-names>CP</given-names></name><name><surname>Woods</surname><given-names>H</given-names></name><name><surname>Nash</surname><given-names>V</given-names></name><name><surname>Gruenhagen</surname><given-names>TC</given-names></name><name><surname>Roushar</surname><given-names>FJ</given-names></name><name><surname>Chandak</surname><given-names>M</given-names></name><name><surname>Hemmerich</surname><given-names>C</given-names></name><name><surname>Rusch</surname><given-names>DB</given-names></name><name><surname>Meiler</surname><given-names>J</given-names></name><name><surname>Schlebach</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Probing biophysical sequence constraints within the transmembrane domains of rhodopsin by deep mutational scanning</article-title><source>Science Advances</source><volume>6</volume><elocation-id>eaay7505</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aay7505</pub-id><pub-id pub-id-type="pmid">32181350</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeffer</surname><given-names>S</given-names></name><name><surname>Dudek</surname><given-names>J</given-names></name><name><surname>Zimmermann</surname><given-names>R</given-names></name><name><surname>Förster</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Organization of the native ribosome-translocon complex at the mammalian endoplasmic reticulum membrane</article-title><source>Biochimica et Biophysica Acta</source><volume>1860</volume><fpage>2122</fpage><lpage>2129</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2016.06.024</pub-id><pub-id pub-id-type="pmid">27373685</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pleiner</surname><given-names>T</given-names></name><name><surname>Tomaleri</surname><given-names>GP</given-names></name><name><surname>Januszyk</surname><given-names>K</given-names></name><name><surname>Inglis</surname><given-names>AJ</given-names></name><name><surname>Hazu</surname><given-names>M</given-names></name><name><surname>Voorhees</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Structural basis for membrane insertion by the human ER membrane protein complex</article-title><source>Science</source><volume>369</volume><fpage>433</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1126/science.abb5008</pub-id><pub-id pub-id-type="pmid">32439656</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popot</surname><given-names>JL</given-names></name><name><surname>Engelman</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Membrane protein folding and oligomerization: the two-stage model</article-title><source>Biochemistry</source><volume>29</volume><fpage>4031</fpage><lpage>4037</lpage><pub-id pub-id-type="doi">10.1021/bi00469a001</pub-id><pub-id pub-id-type="pmid">1694455</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>JV</given-names></name><name><surname>Bershtein</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>A</given-names></name><name><surname>Lozovsky</surname><given-names>ER</given-names></name><name><surname>Hartl</surname><given-names>DL</given-names></name><name><surname>Shakhnovich</surname><given-names>EI</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Biophysical principles predict fitness landscapes of drug resistance</article-title><source>PNAS</source><volume>113</volume><fpage>E1470</fpage><lpage>E1478</lpage><pub-id pub-id-type="doi">10.1073/pnas.1601441113</pub-id><pub-id pub-id-type="pmid">26929328</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sailer</surname><given-names>ZR</given-names></name><name><surname>Harms</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Detecting high-order epistasis in nonlinear genotype-phenotype maps</article-title><source>Genetics</source><volume>205</volume><fpage>1079</fpage><lpage>1088</lpage><pub-id pub-id-type="doi">10.1534/genetics.116.195214</pub-id><pub-id pub-id-type="pmid">28100592</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlebach</surname><given-names>JP</given-names></name><name><surname>Sanders</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The safety dance: biophysics of membrane protein folding and misfolding in a cellular context</article-title><source>Quarterly Reviews of Biophysics</source><volume>48</volume><fpage>1</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1017/S0033583514000110</pub-id><pub-id pub-id-type="pmid">25420508</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shurtleff</surname><given-names>MJ</given-names></name><name><surname>Itzhak</surname><given-names>DN</given-names></name><name><surname>Hussmann</surname><given-names>JA</given-names></name><name><surname>Schirle Oakdale</surname><given-names>NT</given-names></name><name><surname>Costa</surname><given-names>EA</given-names></name><name><surname>Jonikas</surname><given-names>M</given-names></name><name><surname>Weibezahn</surname><given-names>J</given-names></name><name><surname>Popova</surname><given-names>KD</given-names></name><name><surname>Jan</surname><given-names>CH</given-names></name><name><surname>Sinitcyn</surname><given-names>P</given-names></name><name><surname>Vembar</surname><given-names>SS</given-names></name><name><surname>Hernandez</surname><given-names>H</given-names></name><name><surname>Cox</surname><given-names>J</given-names></name><name><surname>Burlingame</surname><given-names>AL</given-names></name><name><surname>Brodsky</surname><given-names>JL</given-names></name><name><surname>Frost</surname><given-names>A</given-names></name><name><surname>Borner</surname><given-names>GH</given-names></name><name><surname>Weissman</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The ER membrane protein complex interacts cotranslationally to enable biogenesis of multipass membrane proteins</article-title><source>eLife</source><volume>7</volume><elocation-id>e37018</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.37018</pub-id><pub-id pub-id-type="pmid">29809151</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smalinskaitė</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>MK</given-names></name><name><surname>Lewis</surname><given-names>AJO</given-names></name><name><surname>Keenan</surname><given-names>RJ</given-names></name><name><surname>Hegde</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Mechanism of an intramembrane chaperone for multipass membrane proteins</article-title><source>Nature</source><volume>611</volume><fpage>161</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-05336-2</pub-id><pub-id pub-id-type="pmid">36261528</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smalinskaitė</surname><given-names>L</given-names></name><name><surname>Hegde</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>The biogenesis of multipass membrane proteins</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>15</volume><elocation-id>a041251</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a041251</pub-id><pub-id pub-id-type="pmid">36096638</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>DiMaio</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>RYR</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Miles</surname><given-names>C</given-names></name><name><surname>Brunette</surname><given-names>T</given-names></name><name><surname>Thompson</surname><given-names>J</given-names></name><name><surname>Baker</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>High-resolution comparative modeling with RosettaCM</article-title><source>Structure</source><volume>21</volume><fpage>1735</fpage><lpage>1742</lpage><pub-id pub-id-type="doi">10.1016/j.str.2013.08.005</pub-id><pub-id pub-id-type="pmid">24035711</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Starr</surname><given-names>TN</given-names></name><name><surname>Thornton</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Epistasis in protein evolution</article-title><source>Protein Science</source><volume>25</volume><fpage>1204</fpage><lpage>1218</lpage><pub-id pub-id-type="doi">10.1002/pro.2897</pub-id><pub-id pub-id-type="pmid">26833806</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sundaram</surname><given-names>A</given-names></name><name><surname>Yamsek</surname><given-names>M</given-names></name><name><surname>Zhong</surname><given-names>F</given-names></name><name><surname>Hooda</surname><given-names>Y</given-names></name><name><surname>Hegde</surname><given-names>RS</given-names></name><name><surname>Keenan</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Substrate-driven assembly of a translocon for multipass membrane proteins</article-title><source>Nature</source><volume>611</volume><fpage>167</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-05330-8</pub-id><pub-id pub-id-type="pmid">36261522</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telenti</surname><given-names>A</given-names></name><name><surname>Pierce</surname><given-names>LCT</given-names></name><name><surname>Biggs</surname><given-names>WH</given-names></name><name><surname>di Iulio</surname><given-names>J</given-names></name><name><surname>Wong</surname><given-names>EHM</given-names></name><name><surname>Fabani</surname><given-names>MM</given-names></name><name><surname>Kirkness</surname><given-names>EF</given-names></name><name><surname>Moustafa</surname><given-names>A</given-names></name><name><surname>Shah</surname><given-names>N</given-names></name><name><surname>Xie</surname><given-names>C</given-names></name><name><surname>Brewerton</surname><given-names>SC</given-names></name><name><surname>Bulsara</surname><given-names>N</given-names></name><name><surname>Garner</surname><given-names>C</given-names></name><name><surname>Metzker</surname><given-names>G</given-names></name><name><surname>Sandoval</surname><given-names>E</given-names></name><name><surname>Perkins</surname><given-names>BA</given-names></name><name><surname>Och</surname><given-names>FJ</given-names></name><name><surname>Turpaz</surname><given-names>Y</given-names></name><name><surname>Venter</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Deep sequencing of 10,000 human genomes</article-title><source>PNAS</source><volume>113</volume><fpage>11901</fpage><lpage>11906</lpage><pub-id pub-id-type="doi">10.1073/pnas.1613365113</pub-id><pub-id pub-id-type="pmid">27702888</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tokuriki</surname><given-names>N</given-names></name><name><surname>Stricher</surname><given-names>F</given-names></name><name><surname>Schymkowitz</surname><given-names>J</given-names></name><name><surname>Serrano</surname><given-names>L</given-names></name><name><surname>Tawfik</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The stability effects of protein mutations appear to be universally distributed</article-title><source>Journal of Molecular Biology</source><volume>369</volume><fpage>1318</fpage><lpage>1332</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2007.03.069</pub-id><pub-id pub-id-type="pmid">17482644</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tokuriki</surname><given-names>N</given-names></name><name><surname>Tawfik</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Stability effects of mutations and protein evolvability</article-title><source>Current Opinion in Structural Biology</source><volume>19</volume><fpage>596</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1016/j.sbi.2009.08.003</pub-id><pub-id pub-id-type="pmid">19765975</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van den Berg</surname><given-names>B</given-names></name><name><surname>Clemons</surname><given-names>WM</given-names><suffix>Jr</suffix></name><name><surname>Collinson</surname><given-names>I</given-names></name><name><surname>Modis</surname><given-names>Y</given-names></name><name><surname>Hartmann</surname><given-names>E</given-names></name><name><surname>Harrison</surname><given-names>SC</given-names></name><name><surname>Rapoport</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>X-ray structure of a protein-conducting channel</article-title><source>Nature</source><volume>427</volume><fpage>36</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1038/nature02218</pub-id><pub-id pub-id-type="pmid">14661030</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viklund</surname><given-names>H</given-names></name><name><surname>Elofsson</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>OCTOPUS: improving topology prediction by two-track ANN-based preference scores and an extended topological grammar</article-title><source>Bioinformatics</source><volume>24</volume><fpage>1662</fpage><lpage>1668</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btn221</pub-id><pub-id pub-id-type="pmid">18474507</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>SH</given-names></name><name><surname>von Heijne</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>How translocons select transmembrane helices</article-title><source>Annual Review of Biophysics</source><volume>37</volume><fpage>23</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1146/annurev.biophys.37.032807.125904</pub-id><pub-id pub-id-type="pmid">18573071</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiseman</surname><given-names>RL</given-names></name><name><surname>Koulov</surname><given-names>A</given-names></name><name><surname>Powers</surname><given-names>E</given-names></name><name><surname>Kelly</surname><given-names>JW</given-names></name><name><surname>Balch</surname><given-names>WE</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Protein energetics in maturation of the early secretory pathway</article-title><source>Current Opinion in Cell Biology</source><volume>19</volume><fpage>359</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2007.05.005</pub-id><pub-id pub-id-type="pmid">17686625</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodall</surname><given-names>NB</given-names></name><name><surname>Hadley</surname><given-names>S</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Bowie</surname><given-names>JU</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Complete topology inversion can be part of normal membrane protein biogenesis</article-title><source>Protein Science</source><volume>26</volume><fpage>824</fpage><lpage>833</lpage><pub-id pub-id-type="doi">10.1002/pro.3131</pub-id><pub-id pub-id-type="pmid">28168866</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wrenbeck</surname><given-names>EE</given-names></name><name><surname>Klesmith</surname><given-names>JR</given-names></name><name><surname>Stapleton</surname><given-names>JA</given-names></name><name><surname>Adeniran</surname><given-names>A</given-names></name><name><surname>Tyo</surname><given-names>KEJ</given-names></name><name><surname>Whitehead</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Plasmid-based one-pot saturation mutagenesis</article-title><source>Nature Methods</source><volume>13</volume><fpage>928</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4029</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>W</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Du</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Qi</surname><given-names>S</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Shao</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Structure of the human gonadotropin-releasing hormone receptor GnRH1R reveals an unusual ligand binding mode</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>5287</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-19109-w</pub-id><pub-id pub-id-type="pmid">33082324</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeldovich</surname><given-names>KB</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Shakhnovich</surname><given-names>EI</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Protein stability imposes limits on organism complexity and speed of molecular evolution</article-title><source>PNAS</source><volume>104</volume><fpage>16152</fpage><lpage>16157</lpage><pub-id pub-id-type="doi">10.1073/pnas.0705366104</pub-id><pub-id pub-id-type="pmid">17913881</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92406.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Drew</surname><given-names>David</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Stockholm University</institution><country>Sweden</country></aff></contrib></contrib-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group><kwd-group kwd-group-type="evidence-strength"><kwd>Solid</kwd></kwd-group></front-stub><body><p>This <bold>important</bold> study describes exhaustive deep mutational scanning (DMS) of the gonadotropin-releasing hormone wild-type receptor and for two single point mutations that impact its folding and structure, monitoring how plasma membrane expression levels are influenced by the introduced mutations. With <bold>solid</bold> evidence, the authors have pioneered an exploration of the interaction between mutations (epistasis) in a membrane protein, with a potential for explaining membrane protein evolution and genetic diseases.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92406.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The paper carries out an impressive and exhaustive non-sense mutagenesis using deep mutational scanning (DMS) of the gonadotropin-releasing hormone receptor for the WT protein and two single point mutations that (i) influences TM insertion (V267T) and (ii) influences protein stability (W107A) and then measures the effect of these mutants on correct plasma membrane expression (PME).</p><p>Overall, most mutations decreased mGnRHR PME levels in all three backgrounds, indicating poor mutational tolerance under these conditions. The W107A variant wasn't really recoverable with low levels of plasma membrane localisation. For the V267T variant, most additional mutations were more deleterious than WT based on correct trafficking, indicating a synergistic effect. As one might expect, there was a higher degree of positive correlation between V267T/W107A mutants and other mutants located in TM regions, confirming that improper trafficking was a likely consequence of membrane protein co-translational folding. Nevertheless, context is important, as positive synergistic mutants in the V27T could be negative in the W107A background and vice versa. Taken together, this important study highlights the complexity of membrane protein folding in dissecting the mechanism-dependent impact of disease-causing mutations related to improper trafficking.</p><p>Strengths:</p><p>This is a novel and exhaustive approach to dissect how receptor mutations under different mutational backgrounds related to co-translational folding, could influence membrane protein trafficking.</p><p>Weaknesses:</p><p>The premise for the study requires an in-depth understanding of how the single point mutations analysed effect membrane protein folding in context of DMS, but the single point mutants used could do with further validation. The V267T mutant only reduced MP insertion by 10% and the effect of W107A on protein stability was not assessed. Furthermore, plasma membrane expression has been used as a proxy for incorrect membrane protein folding, but this not necessarily be the case, as even correctly folded membrane proteins may not be trafficked correctly, at least, under heterologous expression conditions. In addition, mutations can effect trafficking and potential post-translational modifications, like glycosylation.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92406.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In this paper, Chamness and colleagues make a pioneering effort to map epistatic interactions among mutations in a membrane protein. They introduce thousands of mutations to the mouse GnRH Receptor (GnRHR), either under wild-type background or two mutant backgrounds, representing mutations that destabilize GnRHR by distinct mechanisms. The first mutant background is W107A, destabilizing the tertiary fold, and the second, V276T, perturbing the efficiency of cotranslational insertion of TM6 to the membrane, which is essential for proper folding. They then measure surface expression of these three mutant libraries, using it as a proxy for protein stability, since misfolded proteins do not typically make it to the plasma membrane. The resulting dataset is then used to shed light on how diverse mutations interact epistatically with the two genetic background mutations. Their main conclusion is that epistatic interactions vary depending on the degree of destabilization and the mechanism through which they perturb the protein. The mutation V276T forms primarily negative (aggravating) epistatic interactions with many mutations, as is common to destabilizing mutations in soluble proteins. Surprisingly, W107A forms many positive (alleviating) epistatic interactions with other mutations. They further show that the locations of secondary mutations correlate with the types of epistatic interactions they form with the above two mutants.</p><p>Strengths:</p><p>Such a high throughput study for epistasis in membrane proteins is pioneering, and the results are indeed illuminating. Examples of interesting findings are that: (1) No single mutation can dramatically rescue the destabilization introduced by W107A. (2) Epistasis with a secondary mutation is strongly influenced by the degree of destabilization introduced by the primary mutation. (3) Misfolding caused by mis-insertion tends to be aggravated by further mutations. The discussion of how protein folding energetics affects epistasis (Fig. 7) makes a lot of sense and lays out an interesting biophysical framework for the findings.</p><p>Weaknesses:</p><p>The major weakness comes from the potential limitations in the measurements of surface expression of severely misfolded mutants. It seems that only about 5% of the W107A makes it to the plasma membrane compared to wild-type. This point is discussed quite fairly in the paper. (Figures 2 and 3). This might be a low starting point from which to accurately measure the effects of secondary mutations. I am concerned about the extent to which surface expression can report on protein stability, especially when it comes to double mutants where each mutation alone severely decreases surface expression. It is possible that in these cases, both the single and double mutants are completely misfolded, beyond repair. The surface-expressed proteins in such mutants may not be stable, folded or active at all, and the authors do not provide any indication that the combined effects of the mutations are derived from effects on folding stability or misfolding. Therefore, the reason for the epistatic effects of these mutations is hard to interpret, leaving a notable gap in our understanding. However, I find that this point is discussed much more fairly in the current manuscript.</p><p>With that said, I believe that the results regarding the epistasis of V276T with other mutations are strong and very interesting on their own.</p><p>Another concern relates to the measurements of the epistatic effects of mutations in the background of the V107A mutation. I am concerned about their measurement accuracy. Firstly, the authors note that the surface immunostaining measurements of these mutants are on average only 2-fold above background, which is quite a low signal-to-noise regimen. Secondly, I believe that the authors still haven't demonstrated the reproducibility of their surface expression measurements. To showcase the reproducibility, the authors show the correlation of two biological replicates in Figure S3. However, these are shown only for the 251 mutations that passed a reproducibility filter, after the authors &quot;discarded variant scores for which the difference in percentile rank across the two replicates was greater than 25%. &quot; . this means that all mutations that showed irreproducible results were filtered out before the analysis in Figure S3. It is, therefore, no surprise that the remaining mutations are highly reproducible, and such an analysis cannot serve as an indication of the reproducibility. It remains possible that a large fraction of the surface immunostaining scores of the V107A variants are dominated by noise and that their correlation in these two replicates might be random and may not necessarily be reproduced in a third replicate, for example.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92406.3.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chamness</surname><given-names>Laura M</given-names></name><role specific-use="author">Author</role><aff><institution>Indiana University Bloomington</institution><addr-line><named-content content-type="city">Bloomington, IN</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Kuntz</surname><given-names>Charles P</given-names></name><role specific-use="author">Author</role><aff><institution>Purdue University West Lafayette</institution><addr-line><named-content content-type="city">West Lafayette, IN</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>McKee</surname><given-names>Andrew G</given-names></name><role specific-use="author">Author</role><aff><institution>Indiana University Bloomington</institution><addr-line><named-content content-type="city">Bloomington, IN</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Penn</surname><given-names>Wesley D</given-names></name><role specific-use="author">Author</role><aff><institution>Indiana University Bloomington</institution><addr-line><named-content content-type="city">Bloomington, IN</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Hemmerich</surname><given-names>Christopher M</given-names></name><role specific-use="author">Author</role><aff><institution>Indiana University Bloomington</institution><addr-line><named-content content-type="city">Bloomington, IN</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Rusch</surname><given-names>Douglas B</given-names></name><role specific-use="author">Author</role><aff><institution>Indiana University Bloomington</institution><addr-line><named-content content-type="city">Bloomington, IN</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Woods</surname><given-names>Hope</given-names></name><role specific-use="author">Author</role><aff><institution>Vanderbilt University</institution><addr-line><named-content content-type="city">Nashville</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Dyotima</surname><given-names>Dyotima</given-names></name><role specific-use="author">Author</role><aff><institution>Indiana University Bloomington</institution><addr-line><named-content content-type="city">Bloomington, IN</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Meiler</surname><given-names>Jens</given-names></name><role specific-use="author">Author</role><aff><institution>Vanderbilt University</institution><addr-line><named-content content-type="city">Nashville</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Schlebach</surname><given-names>Jonathan P</given-names></name><role specific-use="author">Author</role><aff><institution>Purdue University West Lafayette</institution><addr-line><named-content content-type="city">West Lafayette, IN</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><p>We are grateful for these balanced, nuanced evaluations of our work concerning the observed epistatic trends and our interpretations of their mechanistic origins. Overall, we think the reviewers have done an excellent job at recognizing the novel aspects of our findings while also discussing the caveats associated with our interpretations of the biophysical effects of these mutations. We believe it is important to consider both of these aspects of our work in order to appreciate these advances and what sorts of pertinent questions remain.</p><p>Notably, both reviewers are concerned that our lack of experimental approaches to compare the conformational properties of GnRHR variants weakens our claims. We would first humbly suggest that this constitutes a more general caveat that applies to nearly all investigations of the cellular misfolding of α-helical membrane proteins. Whether or not any current in vitro folding measurements report on conformational transitions that are relevant to cellular protein misfolding reactions remains an active area of debate (discussed further below). Nevertheless, while we concede that our structural and/ or computational evaluations of various mutagenic effects remain speculative, prevailing knowledge on the mechanisms of membrane protein folding suggest our mutations of interest (V276T and W107A) are highly unlikely to promote misfolding in precisely the same way. Thus, regardless of whether or not we were able experimentally compare the relevant folding energetics of GnRHR variants, we are confident that the distinct epistatic interactions formed by these mutations reflect variations in the misfolding mechanism and that they are distinct from the interactions that are observed in the context of stable proteins. In the following, we provide detailed considerations concerning these caveats in relation to the reviewers’ specific comments.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public Review):</bold></p><p>The paper carries out an impressive and exhaustive non-sense mutagenesis using deep mutational scanning (DMS) of the gonadotropin-releasing hormone receptor for the WT protein and two single point mutations that (I) influence TM insertion (V267T) and (ii) influence protein stability (W107A), and then measures the effect of these mutants on correct plasma membrane expression (PME).</p><p>Overall, most mutations decreased mGnRHR PME levels in all three backgrounds, indicating poor mutational tolerance under these conditions. The W107A variant wasn't really recoverable with low levels of plasma membrane localisation. For the V267T variant, most additional mutations were more deleterious than WT based on correct trafficking, indicating a synergistic effect. As one might expect, there was a higher degree of positive correlation between V267T/W107A mutants and other mutants located in TM regions, confirming that improper trafficking was a likely consequence of membrane protein co-translational folding. Nevertheless, context is important, as positive synergistic mutants in the V27T could be negative in the W107A background and vice versa. Taken together, this important study highlights the complexity of membrane protein folding in dissecting the mechanism-dependent impact of disease-causing mutations related to improper trafficking.</p><p>Strengths</p><p>This is a novel and exhaustive approach to dissecting how receptor mutations under different mutational backgrounds related to co-translational folding, could influence membrane protein trafficking.</p><p>Weaknesses</p><p>The premise for the study requires an in-depth understanding of how the single-point mutations analysed affect membrane protein folding, but the single-point mutants used seem to lack proper validation.</p></disp-quote><p>Given our limited understanding of the structural properties of misfolded membrane proteins, it is unclear whether the relevant conformational effects of these mutations can be unambiguously validated using current biochemical and/ or biophysical folding assays. X-ray crystallography, cryo-EM, and NMR spectroscopy measurements have demonstrated that many purified GPCRs retain native-like structural ensembles within certain detergent micelles, bicelles, and/ or nanodiscs. However, helical membrane protein folding measurements typically require titration with denaturing detergents to promote the formation of a denatured state ensemble (DSE), which will invariably retain considerable secondary structure. Given that the solvation provided by mixed micelles is clearly distinct from that of native membranes, it remains unclear whether these DSEs represent a reasonable proxy for the misfolded conformations recognized by cellular quality control (QC, see <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/acs.chemrev.8b00532">https://doi.org/10.1021/acs.chemrev.8b00532</ext-link>). Thus, the use and interpretation of these systems for such purposes remains contentious in the membrane protein folding community. In addition to this theoretical issue, we are unaware of any instances in which GPCRs have been found to undergo reversible denaturation in vitro- a practical requirement for equilibrium folding measurements (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev-biophys-051013-022926">https://doi.org/10.1146/annurev-biophys-051013-022926</ext-link>). We note that, while the resistance of GPCRs to aggregation, proteolysis, and/ or mechanical unfolding have also been probed in micelles, it is again unclear whether the associated thermal, kinetic, and/ or mechanical stability should necessarily correspond to their resistance to cotranslational and/ or posttranslational misfolding. Thus, even if we had attempted to validate the computational folding predictions employed herein, we suspect that any resulting correlations with cellular expression may have justifiably been viewed by many as circumstantial. Simply put, we know very little about the non-native conformations are generally involved in the cellular misfolding of α-helical membrane proteins, much less how to measure their relative abundance. From a philosophical standpoint, we prefer to let cells tell us what sorts of broken protein variants are degraded by their QC systems, then do our best to surmise what this tells us about the relevant properties of cellular DSEs.</p><p>Despite this fundamental caveat, we believe that the chosen mutations and our interpretation of their relevant conformational effects are reasonably well-informed by current modeling tools and by prevailing knowledge on the physicochemical drivers of membrane protein folding and misfolding. Specifically, the mechanistic constraints of translocon-mediated membrane integration provide an understanding of the types of mutations that are likely to disrupt cotranslational folding. Though we are still learning about the protein complexes that mediate membrane translocation (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41586-022-05336-2">https://doi.org/10.1038/s41586-022-05336-2</ext-link>), it is known that this underlying process is fundamentally driven by the membrane depth-dependent amino acid transfer free energies (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev.biophys.37.032807.125904">https://doi.org/10.1146/annurev.biophys.37.032807.125904</ext-link>). This energetic consideration suggests introducing polar side chains near the center of a nascent TMDs should almost invariably reduce the efficiency of topogenesis. To confirm this in the context of TMD6 specifically, we utilized a well-established biochemical reporter system to confirm that V276T attenuates its translocon-mediated membrane integration (Fig. S1)- at least in the context of a chimeric protein. We also constructed a glycosylation-based topology reporter for full-length GnRHR, but ultimately found its’ in vitro expression to be insufficient to detect changes in the nascent topological ensemble.</p><p>In contrast to V276T, the W107A mutation is predicted to preserve the native topological energetics of GnRHR due to its position within a soluble loop region. W107A is also unlike V276T in that it clearly disrupts tertiary interactions that stabilize the native structure. This mutation should preclude the formation of a structurally conserved hydrogen bonding network that has been observed in the context of at least 25 native GPCR structures (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7554/eLife.5489">https://doi.org/10.7554/eLife.5489</ext-link>). However, without a relevant folding assay, the extent to which this network stabilizes the native GnRHR fold in cellular membranes remains unclear. Overall, we admit that these limitations have prevented us from measuring how much V276T alters the efficiency of GnRHR topogenesis, how much the W107A destabilizes the native fold, or vice versa. Nevertheless, given these design principles and the fact that both reduce the plasma membrane expression of GnRHR, as expected, we are highly confident that the structural defects generated by these mutations do, in fact, promote misfolding in their own ways. We also concede that the degree to which these mutagenic perturbations are indeed selective for specific folding processes is somewhat uncertain. However, it seems exceedingly unlikely that these mutations should disrupt topogenesis and/ or the folding of the native topomer to the exact same extent. From our perspective, this is the most important consideration with respect to the validity of the conclusions we have made in this manuscript.</p><disp-quote content-type="editor-comment"><p>Furthermore, plasma membrane expression has been used as a proxy for incorrect membrane protein folding, but this not necessarily be the case, as even correctly folded membrane proteins may not be trafficked correctly, at least, under heterologous expression conditions. In addition, mutations can affect trafficking and potential post-translational modifications, like glycosylation.</p></disp-quote><p>While the reviewer is correct that the sorting of folded proteins within the secretory pathway is generally inefficient, it is also true that the maturation of nascent proteins within the ER generally bottlenecks the plasma membrane expression of most α-helical membrane proteins. Our group and several others have demonstrated that the efficiency of ER export generally appears to scale with the propensity of membrane proteins to achieve their correct topology and/ or to achieve their native fold (see <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/jacs.5b03743">https://doi.org/10.1021/jacs.5b03743</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/jacs.8b08243">https://doi.org/10.1021/jacs.8b08243</ext-link>). Notably, these investigations all involved proteins that contain native glycosylation and various other post-translational modification sites. While we cannot rule out that certain specific combinations of mutations may alter expression through their perturbation of post-translational GnRHR modifications, we feel confident that the general trends we have observed across hundreds of variants predominantly reflect changes in folding and cellular QC. This interpretation is supported by the relationship between observed trends in variant expression and Rosetta-based stability calculations, which we identified using unbiased unsupervised machine learning approaches (compare Figs. 6B &amp; 6D).</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>Summary:</p><p>In this paper, Chamness and colleagues make a pioneering effort to map epistatic interactions among mutations in a membrane protein. They introduce thousands of mutations to the mouse GnRH Receptor (GnRHR), either under wild-type background or two mutant backgrounds, representing mutations that destabilize GnRHR by distinct mechanisms. The first mutant background is W107A, destabilizing the tertiary fold, and the second, V276T, perturbing the efficiency of cotranslational insertion of TM6 to the membrane, which is essential for proper folding. They then measure the surface expression of these three mutant libraries, using it as a proxy for protein stability, since misfolded proteins do not typically make it to the plasma membrane. The resulting dataset is then used to shed light on how diverse mutations interact epistatically with the two genetic background mutations. Their main conclusion is that epistatic interactions vary depending on the degree of destabilization and the mechanism through which they perturb the protein. The mutation V276T forms primarily negative (aggravating) epistatic interactions with many mutations, as is common to destabilizing mutations in soluble proteins. Surprisingly, W107A forms many positive (alleviating) epistatic interactions with other mutations. They further show that the locations of secondary mutations correlate with the types of epistatic interactions they form with the above two mutants.</p><p>Strengths:</p><p>Such a high throughput study for epistasis in membrane proteins is pioneering, and the results are indeed illuminating. Examples of interesting findings are that: (1) No single mutation can dramatically rescue the destabilization introduced by W107A. (2) Epistasis with a secondary mutation is strongly influenced by the degree of destabilization introduced by the primary mutation. (3) Misfolding caused by mis-insertion tends to be aggravated by further mutations. The discussion of how protein folding energetics affects epistasis (Fig. 7) makes a lot of sense and lays out an interesting biophysical framework for the findings.</p><p>Weaknesses:</p><p>The major weakness comes from the potential limitations in the measurements of surface expression of severely misfolded mutants. This point is discussed quite fairly in the paper, in statements like &quot;the W107A variant already exhibits marginal surface immunostaining&quot; and many others. It seems that only about 5% of the W107A makes it to the plasma membrane compared to wild-type (Figures 2 and 3). This might be a low starting point from which to accurately measure the effects of secondary mutations.</p></disp-quote><p>The reviewer raises an excellent point that we considered at length during the analysis of these data and the preparation of the manuscript. Though we remain confident in the integrity of these measurements and the corresponding analyses, we now realize this aspect of the data required further discussion and documentation which we have provided in the revised version of the manuscript as is described in the following.</p><disp-quote content-type="editor-comment"><p>Still, the authors claim that measurements of W107A double mutants &quot;still contain cellular subpopulations with surface immunostaining intensities that are well above or below that of the W107A single mutant, which suggests that this fluorescence signal is sensitive enough to detect subtle differences in the PME of these variants&quot;. I was not entirely convinced that this was true.</p></disp-quote><p>We made this statement based on the simple observation that the surface immunostaining intensities across the population of recombinant cells expressing the library of W107A double mutants was consistently broader than that of recombinant cells expressing W107A GnRHR alone (see Author response image 1 for reference). Given that the recombinant cellular library represents a mix of cells expressing ~1600 individual variants that are each present at low abundance, the pronounced tails within this distribution presumably represent the composite staining of many small cellular subpopulations that express collections of variants that deviate from the expression of W107A to an extent that is significant enough to be visible on a log intensity plot.</p><fig id="sa3fig1" position="float"><label>Author response image 1.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92406-sa3-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>Firstly, I think it would be important to test how much noise these measurements have and how much surface immunostaining the W107A mutant displays above the background of cells that do not express the protein at all.</p></disp-quote><p>For reference, the average surface immunostaining intensity of HEK293T cells transiently expressing W107A GnRHR was 2.2-fold higher than that of the IRES-eGFP negative, untransfected cells within the same sample- the WT immunostaining intensity was 9.5-fold over background by comparison. Similarly, recombinant HEK293T cells expressing the W107A double mutant library had an average surface immunostaining intensity that was 2.6-fold over background across the two DMS trials. Thus, while the surface immunostaining of this variant is certainly diminished, we were still able to reliably detect W107A at the plasma membrane even under distinct expression regimes. We have included these and other signal-to-noise metrics for each experiment in the Results section of the revised manuscript.</p><p>Beyond considerations related to intensity, we also previously noticed the relative intensity values for W107A double mutants exhibited considerable precision across our two biological replicates. If signal were too poor to detect changes in variant expression, we would have expected a plot of the intensity values across these two replicates to form a scatter. Instead, we found DMS intensity values for individual variants to be highly correlated from one replicate to the next (Pearson’s R2 = 0.95, see Author response image 2 for reference). This observation empirically demonstrates that this assay consistently differentiated between variants that exhibit slightly enhanced immunostaining from those that have even lower immunostaining than W107A GnRHR. We have included these discussion points in the Results section as well as scatter plots for replicate variant intensities within all three genetic backgrounds in Figure S3 of the revised manuscript.</p><fig id="sa3fig2" position="float"><label>Author response image 2.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92406-sa3-fig2-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>But more importantly, it is not clear if under this regimen surface expression still reports on stability/protein fitness. It is unknown if the W107A retains any function or folding at all. For example, it is possible that the low amount of surface protein represents misfolded receptors that escaped the ER quality control.</p></disp-quote><p>While we believe that such questions are outside the scope of this work, we certainly agree that it is entirely possible that some of these variants bypass QC without achieving their native fold. This topic is quite interesting to us but is quite challenging to assess in the context of GPCRs, which have complex fitness landscapes that involve their propensity to distinguish between different ligands, engage specific components associated with divergent downstream signaling pathways, and navigate between endocytic recycling/ degradation pathways following activation. In light of the inherent complexity of GPCR function, we humbly suggest our choice of a relatively simple property of an otherwise complex protein may be viewed as a virtue rather than a shortcoming. Protein fitness is typically cast as the product of abundance and activity. Rather than measuring an oversimplified, composite fitness metric, we focused on one variable (plasma membrane expression) and its dominant effector (folding). We believe restraining the scope in this manner was key for the elucidation of clear mechanistic insights.</p><disp-quote content-type="editor-comment"><p>The differential clustering of epistatic mutations (Fig. 6) provides some interesting insights as to the rules that dictate epistasis, but these too are dominated by the magnitude of destabilization caused by one of the mutations. In this case, the secondary mutations that had the most interesting epistasis were exceedingly destabilizing. With this in mind, it is hard to interpret the results that emerge regarding the epistatic interactions of W107A. Furthermore, the most significant positive epistasis is observed when W107A is combined with additional mutations that almost completely abolish surface expression. It is likely that either mutation destabilizes the protein beyond repair. Therefore, what we can learn from the fact that such mutations have positive epistasis is not clear to me. Based on this, I am not sure that another mutation that disrupts the tertiary folding more mildly would not yield different results. With that said, I believe that the results regarding the epistasis of V276T with other mutations are strong and very interesting on their own.</p></disp-quote><p>We agree with the reviewer. In light of our results we believe it is virtually certain that the secondary mutations characterized herein would be likely to form distinct epistatic interactions with mutations that are only mildly destabilizing. Indeed, this insight reflects one of the key takeaway messages from this work- stability-mediated epistasis is difficult to generalize because it should depend on the extent to which each mutation changes the stability (ΔΔG) as well as initial stability of the WT/ reference sequence (ΔG, see Figure 7). Frankly, we are not so sure we would have pieced this together as clearly had we not had the fortune (or misfortune?) of including such a destructive mutation like W107A as a point of reference.</p><disp-quote content-type="editor-comment"><p>Additionally, the study draws general conclusions from the characterization of only two mutations, W107A and V276T. At this point, it is hard to know if other mutations that perturb insertion or tertiary folding would behave similarly. This should be emphasized in the text.</p></disp-quote><p>We agree. Our findings suggest different mutations may not behave similarly, which we believe is a key finding of this work. We have emphasized this point in the Discussion section of the revised manuscript as follows:</p><p>“These findings suggest the folding-mediated epistasis is likely to vary among different classes of destabilizing mutations in a manner that should also depend on folding efficiency and/ or the mechanism(s) of misfolding in the cell.”</p><disp-quote content-type="editor-comment"><p>Some statistical aspects of the study could be improved:</p><p>(1) It would be nice to see the level of reproducibility of the biological replicates in a plot, such as scatter or similar, with correlation values that give a sense of the noise level of the measurements. This should be done before filtering out the inconsistent data.</p></disp-quote><p>We thank the reviewer for this suggestion and will include scatters for each genetic background like the one shown above in Figure S3 of the revised version of the manuscript.</p><disp-quote content-type="editor-comment"><p>(2) The statements &quot;Variants bearing mutations within the C- terminal region (ICL3-TMD6-ECL3-TMD7) fare consistently worse in the V276T background relative to WT (Fig. 4 B &amp; E).&quot; and &quot;In contrast, mutations that are 210 better tolerated in the context of W107A mGnRHR are located 211 throughout the structure but are particularly abundant among residues 212 in the middle of the primary structure that form TMD4, ICL2, and ECL2 213 (Fig. 4 C &amp; F).&quot; are both hard to judge. Inspecting Figures 4B and C does not immediately show these trends, and importantly, a solid statistical test is missing here. In Figures 4E and F the locations of the different loops and TMs are not indicated on the structure, making these statements hard to judge.</p></disp-quote><p>We apologize for this oversight and thank the reviewer for pointing this out. We utilized paired Wilcoxon-Signed Rank Tests to evaluate the statistical significance of these observations and modified the description of these findings in the revised version of the results section as follows:</p><p>“Variants bearing mutations within the C-terminal regions including ICL3, TMD6, and TMD7 fare consistently worse in the V276T background relative to WT (paired Wilcoxon-Signed Rank Test p-values of 0.0001, 0.02, and 0.005, respectively) (Fig. 4 B &amp; E). Given that V276T perturbs the cotranslational membrane integration of TMD6 (Fig. S1, Table S1), this directional bias potentially suggests that the apparent interactions between these mutations manifest during the late stages of cotranslational folding. In contrast, mutations that are better tolerated in the context of W107A mGnRHR are located throughout the structure but are particularly abundant among residues in the middle of the primary structure that form ICL2, TMD4, and ECL2 (paired Wilcoxon-Signed Rank Test p-values of 0.0005, 0.0001, and 0.004, respectively) (Fig. 4 C &amp; F).”</p><disp-quote content-type="editor-comment"><p>(3) The following statement lacks a statistical test: &quot;Notably, these 98 variants are enriched with TMD variants (65% TMD) relative to the overall set of 251 variants (45% TMD).&quot; Is this enrichment significant? Further in the same paragraph, the claim that &quot;In contrast to the sparse epistasis that is generally observed between mutations within soluble proteins, these findings suggest a relatively large proportion of random mutations form epistatic interactions in the context of unstable mGnRHR variants&quot;. Needs to be backed by relevant data and statistics, or at least a reference.</p></disp-quote><p>We thank the reviewer for this reasonable suggestion. In the revised manuscript, we included the results of a paired Wilcoxon-Signed Rank Test that confirms the statistical significance of this observation and modified the Results section to reflect this as follows:</p><p>“Notably, these 98 variants are enriched with TMD variants (65% TMD) relative to the overall set of 251 variants (45% TMD, Fisher’s Exact Test p = 0.0019). These findings suggest random mutations form epistatic interactions in the context of unstable mGnRHR variants in a manner that depends on the specific folding defect (V276T vs. W107A) and topological context.”</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Recommendations for the Authors):</bold></p><p>As far as this reviewer is aware, the effect of the V267T variant on MP insertion has not been measured directly; its position corresponds to T277 in TMD6 of human GnRHR that has been measured for TM insertion, but given the clear lack of conservation (threonine vs valine) the mutation in TM6 could potentially have a different impact on the mouse homologue. Please clarify what the predicted delta TM for insertion is between human and mouse GnRHR is? Moreover, I would argue that single TM insertion by tethering to Lep is insufficient to understand MP insertion/folding, as neighbouring TM helices could help to drive TM6 insertion. Has ER microsome experiments for mouse GnRHR also been carried out in the context of neighbouring helices?</p></disp-quote><p>We included measurements (and predictions) of the impact of the V276T substitution on the translocon-mediated membrane integration of the mouse TMD6 in the context of a chimeric Lep protein (see Fig. S1 &amp; Table S1). Our results reveal that this substitution decreases the efficiency of TMD6 membrane integration by ~10%. Though imperfect, this prevailing biochemical assay remains popular for a variety of theoretical and technical reasons. Importantly, extensive experimental testing of this system has shown that these measurements report apparent equilibrium constants that are well-described by two-state equilibrium partitioning models (see DOIs 10.1038/nature03216 and 10.1038/nature06387). This observation provides a reasonable rationale to interpret these measurements using energetic models as we have in this work (see Table S1). From a technical perspective, the Lep system is also advantageous due to the fact that this protein is generally well expressed in the context of in vitro translation systems containing native membranes, which generally ensures a consistent signal to noise and dynamic range for membrane integration measurements. Nevertheless, the reviewers are correct that membrane integration efficiencies are likely distinct in the context of the native mGnRHR protein. For these reasons, we attempted to develop a glycosylation-based topology reporter prior to the posting and submission of this manuscript. However, all GnRHR reporters we tested were poorly expressed in vitro and the resulting 35S-labeled proteins only generated faint smears on our phosphorimaging screens that could not be interpreted. For these reasons, we chose to rely the Lep measurements for these investigations.</p><p>The lack of a more relevant topological reporter is one of many challenges we faced in our investigations of this unstable, poorly behaved protein. We share the reviewer’s frustrations concerning the speculative aspects of this work. Nevertheless, there is increasing appreciation for the fact that our perspectives on protein biophysics have been skewed by our continuing choice to focus on the relatively small set of model proteins that are compatible with our favored methodologies (doi: 10.1016/j.tibs.2013.05.001). We humbly suggest this work represents an example of how we can gain a deeper understanding of the limits of biochemical systems when we instead choose to study the unsavory bits of cellular proteomes. But this choice requires a willingness to make some reasonable assumptions and to lean on energetic/ structural modeling from time to time. Despite this limitation, we believe there is still tremendous value in this compromise.</p><disp-quote content-type="editor-comment"><p>What is the experimental evidence the W107A variant affects the protein structure? Has its melting temperature with and without inverse agonist binding for WT vs the W107A variant been measured, for example? Even heat-FSEC of detergent-solubilised membranes would be informative to know how unstable the W107A variant is. If is very unstable in detergent, then it could be that recovery mutants are going to be unlikely as you are already starting with a poor construct showing poor folding/localisation.</p></disp-quote><p>We again understand the rationale for this concern, but do not believe that thermal melting measurements are likely to report the same sorts of conformational transitions involved in cellular misfolding. Heating up a protein to the point in which membranes (or micelles) are disrupted and the proteins begin to form insoluble aggregates is a distinct physical process from those that occur during co- and post-translational folding within intact ER membranes at physiological temperatures (discussed further in the Response to the Reviews). Indeed, as the reviewer points out below, there seems to be little evidence that secretion is linked to thermal stability or various other metrics that others have attempted to optimize for the sake of purification and/ or structural characterization. Thus, we believe it would be just as speculative to suggest thermal aggregation represents a relevant metric for the propensity of membrane proteins to fold in the cell. The physical interpretation of membrane protein misfolding reaction remains contentious in our field due to the key fact that the denatured states of helical membrane proteins remain highly structured in a manner that is hard to generalize beyond the fact that the denatured states retain α-helical secondary structure (doi: 10.1146/annurev-biophys-051013-022926). This is in stark contrast to soluble proteins, where random coil reference states have proven to be generally useful for energetic interpretations of protein stability. For reference, our lab is currently working to leverage epistatic measurements like this to map the prevailing physiological denatured states of an integral membrane protein. Our current findings suggest that non-native electrostatic interactions form in the context of misfolded states. We hope that more information on the structural aspects of these states will help us to develop and interpret meaningful folding measurements within the membrane.</p><p>For reference, even in cases when quantitative folding measurements can be achieved, their relevance remains actively debated. As a point of reference, the corresponding author of this work previously worked on the stability and misfolding of another human α-helical membrane protein (PMP22). Like GnRHR, PMP22 is prone to misfolding in the secretory pathway and is associated with dozens of pathogenic mutations that cause protein misfolding. To understand how the thermodynamic stability of this protein is linked to secretion, the corresponding author purified PMP22, reconstituted it into n-Dodecyl-phosphocholine (DPC) micelles, and measured its resistance to denaturation by an anionic denaturing detergent (Lauryl Sarcosine, LS). The results were initially perplexing due to the fact that equilibrium unfolding curves manifested as an exponential decay (rather than a sigmoid) and relaxation kinetics appeared to be dominated by the rate constant for unfolding (doi: 10.1021/bi301635f). Unfortunately, these data could not be fit with existing folding models due to the lack of a folded protein baseline and the absence of a folding arm in the chevron plot. We eventually found that a full sigmoidal unfolding transition and refolding kinetics could be measured upon addition of 15% (v/v) glycerol. Our measurements revealed that the free energy of unfolding in DPC micelles was 0 kcal/ mol (without glycerol). This shocking lack of WT stability made it impossible to directly measure the effects of destabilizing mutations that enhance misfolding- you can’t measure the unfolding of a protein that is already unfolded. We ultimately had to instead infer the energetic effects of such mutations from the thermodynamic coupling between cofactor binding and folding (doi: 10.1021/jacs.5b03743). Finally, after demonstrating the resulting ΔΔGs correlated with both cellular trafficking and disease phenotype, we still faced justified scrutiny about the relevance of these measurements due to the fact that they were carried out in micelles. For these reasons, we do not feel that additional biophysical measurements will add much to this work until more is understood about the nature of misfolding reactions in the membrane and how to effectively recapitulate it in vitro. We also note that PMP22 is secreted with 20% efficiency in mammalian cell lines, which is 20-fold more efficient than human GnRHR under similar conditions (doi: 10.1016/j.celrep.2021.110046). Thus, we suspect equilibrium unfolding measurements are likely out of reach using previously described measurements.</p><p>Our greatest evidence suggesting W107A destabilizes the protein has to do with the fact that it deletes a highly conserved structural contact and that this structural modification kills its secretion. The fact that this mutation clearly reduces the escape of GnRHR from ER quality control is a classic indicator of misfolding that represents the cell’s way of telling us that the mutation compromises the folding of the nascent protein in some way or another. Precisely how this mutation remodels the nascent conformational ensemble of nascent GnRHR and how this relates to the free energy difference between the native and non-native portions of its conformational ensemble under cellular conditions is a much more challenging question that lies beyond the scope of this investigation (and likely beyond the scope of what’s currently possible). Indeed, there is an entire field dedicated to understanding such. Nevertheless, the difference in the epistatic interactions formed by W107A and V276T is at the very least consistent with our speculative interpretation that these two mutations vary in their misfolding mechanism and/ or in the extent to which they destabilize the protein. For these reasons, we feel the main conclusions of this manuscript are well-justified.</p><disp-quote content-type="editor-comment"><p>Please clarify if the protein is glycosylated or not and, if it is, how would this requirement affect the conclusions of your analysis?</p></disp-quote><p>As we noted in the Response to the Reviewers, which also constitutes a published portion of the final manuscript, this protein is indeed glycosylated. We were well aware of this aspect of the protein since inception of this project and do not think this changes our interpretation at all. Most membrane proteins are glycosylated, and several groups have demonstrated in various ways that the secretion efficiency of glycoproteins is proportional to certain stability metrics for secreted soluble proteins and membrane proteins alike. Generally, mutations that enhance misfolding do not change the propensity of the nascent chain to undergo N-linked glycosylation, which occurs during translation before protein synthesis and/ or folding is complete. Misfolded proteins typically carry lower weight glycans, which reflects their failure to advance from the ER to the Golgi, where N-linked glycans are modified and O-linked glycans are added. From our perspective, glycosyl modifications just ensure that nascent proteins are engaged by calnexin and other lectin chaperones involved in QC. It does not decouple folding from secretion efficiency. In the case of PMP22 (described above), we found that removal of its glycosylation site allows the nascent protein to bypass the lectin chaperones in a manner that enhances its plasma membrane expression eight-fold (doi: 10.1016/j.jbc.2021.100719). Similar to WT, the expression of several misfolded PMP22 variants also significantly increases upon removal of the glycosylation site. Nevertheless, their expression is still significantly lower than the un-glycosylated WT protein, and the expression patterns of the mutants relative to WT was quite similar across this panel of un-glycosylated proteins. Thus, while glycosylation certainly impacts secretion, it does not change its dependence on folding efficiency within the ER. There are many layers of partially redundant QC within the ER, and it seems that folding imposes a key bottleneck to secretion regardless of which QC proteins are involved. For these reasons, we do not think glycosylation (or other PTMs) should factor into our interpretation of these results.</p><disp-quote content-type="editor-comment"><p>One caveat with the study is that there is a poor understanding of the factors that decide if the protein should be trafficked to the PM or not. Even secretory proteins not going through the calnexin/reticulum cycle (as they have no N-linked glycans), might still get stuck in the ER, despite the fact they are functional. Could this be a technical issue of heterologous expression overloading the Sec system?</p></disp-quote><p>While we agree that there is much to be learned about this topic, we disagree with the notion that our understanding of folding and secretion is insufficient to generally interpret the molecular basis of the observed trends. In collaboration with various other groups, the corresponding author of this paper has shown for several other proteins that the stability of the native topology and the native tertiary structure can constrain secretion efficiency (see dois: 10.1021/jacs.8b08243, 10.1021/jacs.5b03743, and 10.1016/j.jbc.2021.100423). Moreover, the Balch and Kelly groups demonstrated many years ago that relatively simple models for the coupling between folding and chaperone binding can recapitulate the observed effects of mutations on the secretion efficiency of various proteins (doi: 10.1016/j.cell.2007.10.025). Given a wide body of prevailing knowledge in this area, we believe it is entirely reasonable to assume that the conformational effects of these mutation have a dominant effect on plasma membrane expression.</p><p>Whether or not some of the proteins retained in the ER are folded and/ or functional is an interesting question, but is outside the scope of this work. Various lines of evidence concerning approaches to rescue misfolded membrane proteins suggest many of these variants are likely to retain residual function once they escape the ER, which may suggest there are pockets of foldable/ folded proteins within the ER. But it seems generally clear that the efficiency of folding in the ER bottlenecks secretion regardless of whether or not the ER contains some fraction of folded/ functional protein. We note that it is certainly possible, if not likely, that secretion efficiency is likely to be higher at lower expression levels (doi: 10.1074/jbc.AC120.014940). However, the mutational scanning platform used in this work was designed such that all variants are expressed from an identical promoter at the same location within the genome. Thus, for the purposes of these investigations, we believe it is entirely fair to draw “apples-to-apples” comparisons of their relative effects on plasma membrane expression.</p><disp-quote content-type="editor-comment"><p>Please see Francis Arnold's paper on this point and their mutagenesis library of the channelrhodopsin (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/doi/10.1073/pnas.1700269114">https://www.pnas.org/doi/10.1073/pnas.1700269114</ext-link>), which further found that 20% of mutations improved WT trafficking. Some general comparisons to this paper might be informative.</p></disp-quote><p>We agree that it may be interesting to compare the results from this paper to those in our own. Indeed, we find that 20% of the point mutations characterized herein also enhance the expression of WT mGnRHR, as mentioned in the Results section. However, we think it might be a bit premature to suggest this is a more general trend in light of the fact that the channelrhodopsins engineered in those studies were not of eukaryotic origin and have likely resulted from distinct evolutionary constraints. We ultimately decided against adding more on this to our already lengthy discussion in order to maintain focus on the mechanisms of epistasis.</p><disp-quote content-type="editor-comment"><p>Chris Tate and others have shown that there is a high frequency of finding stabilising point mutations in GPCRs and this is the premise of the StAR technology used to thermostabilise GPCRs in the presence of different ligands, i.e. agonist vs inverse agonists. As far as I am aware, there is a poor correlation between expression levels and thermostability (measured by ligand binding to detergent-solubilised membranes). As such, it is possible that some of the mutants might be more stable than WT even though they have lower levels of PME.</p></disp-quote><p>We believe the disconnect between thermostability and expression precisely speaks to our main point about the suitability of current membrane protein folding assays for the questions we address herein. The degradative activity of ER quality control has not necessarily selected for proteins that are resistant to thermal degradation and/ or are suitable for macromolecular crystallography. For this reason, it is often not so difficult to engineer proteins with enhanced thermal stability. We do not believe this disconnect signals that quality control is insensitive to protein folding and stability, but rather that it is more likely to recognize conformational defects that are distinct from those involved in thermal degradation and/ or aggregation. Indeed, recent work from the Fluman group, which builds on a wider body of previous observations, has shown that the exposure of polar groups within the membrane is a key factor that recruits degradation machinery (doi: 0.1101/2023.12.12.571171). It is hard to imagine that these sorts of conformational defects are the same as those involved in thermal aggregation.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations For The Authors):</bold></p><p>(1) I believe that by focusing more on the epistasis with V276T, and less on W107A, the paper could be strengthened significantly.</p></disp-quote><p>We appreciate this sentiment. But we believe the comparison of these two mutants really drive home the point that destabilizing mutations are not equivalent with respect to the epistatic interactions they form.</p><disp-quote content-type="editor-comment"><p>(2) In the abstract - please define the term epistasis in a simple way, to make it accessible to a general audience. For example - negative epistasis means that... this should be explicitly explained.</p></disp-quote><p>We thank the reviewer for this suggestion. To meet eLife formatting, we had to cut down the abstract significantly. We simplified this as best we could in the following statement:</p><p>“Though protein stability is known to shape evolution, it is unclear how cotranslational folding constraints modulate the synergistic, epistatic interactions between mutations.”</p><p>We also define positive and negative epistasis in the results section as follows:</p><p>“Positive Ɛ values denote double mutants that have greater PME than would be expected based on the effects of single mutants. Negative Ɛ values denote double mutants that have lower PME than would be expected based on the effects of single mutants. Pairs of mutations with Ɛ values near zero have additive effects on PME.”</p><disp-quote content-type="editor-comment"><p>(3) The title is quite complex and might deter readers from outside the protein evolution field. Consider simplifying it.</p></disp-quote><p>We thank the reviewer for this suggestion. We have simplified the title to the following:</p><p>“Divergent Folding-Mediated Epistasis Among Unstable Membrane Protein Variants”</p><disp-quote content-type="editor-comment"><p>(4) The paper could benefit from a simple figure explaining the different stages of membrane protein folding (stages 1+2) to make it more accessible to readers from outside the membrane protein field.</p></disp-quote><p>This is a great suggestion. We incorporated a new schematic in the revised manuscript that outlines the nature of these processes (see Fig. 1A in the revised manuscript).</p><disp-quote content-type="editor-comment"><p>(5) For the FACS-Seq experiment - it was not clear to me if and when all cells are pulled together. For example - are the 3 libraries mixed together already at the point of transfection, or are the transfected cells pulled together at any point before sorting? This could have some implications on batch effects and should, therefore, be explicitly mentioned in the main text.</p></disp-quote><p>We thank the reviewer for this suggestion. We modified the description of the DNA library assembly to emphasize that the mutations were generated in the context of three mixed plasmid pools, which were then transfected into the cells and sorted independently:</p><p>“We then generated a mixed array of mutagenic oligonucleotides that collectively encode this series of substitutions (Table S3) and used nicking mutagenesis to introduce these mutations into the V276T, W107A, and WT mGnRHR cDNAs (Medina-Cucurella et al., 2019), which produced three mixed plasmid pools.”</p><disp-quote content-type="editor-comment"><p>(6) The following description in the text is quite confusing. It would be better to simplify it considerably or remove it: &quot;scores (Ɛ) were then determined by taking the log of the double mutant fitness value divided by the difference between the single mutant fitness values (see Methods).&quot;</p></disp-quote><p>We thank the reviewer for this valuable feedback and have simplified the text as follows:</p><p>“To compare epistatic trends in these libraries, we calculated epistasis scores (Ɛ) for the interactions that these 251 mutations form with V276T and W107A by comparing their relative effects on PME of the WT, V276T, and W107A variants using a previously described epistasis model (product model, see Methods) (Olson et al. 2014).”</p></body></sub-article></article>